<SEC-DOCUMENT>0001654954-24-014612.txt : 20241118
<SEC-HEADER>0001654954-24-014612.hdr.sgml : 20241118
<ACCEPTANCE-DATETIME>20241118161023
ACCESSION NUMBER:		0001654954-24-014612
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20241114
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241118
DATE AS OF CHANGE:		20241118

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			374Water Inc.
		CENTRAL INDEX KEY:			0000933972
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTORS & GENERATORS [3621]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				880271109
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41420
		FILM NUMBER:		241471568

	BUSINESS ADDRESS:	
		STREET 1:		701 W. MAIN STREET
		STREET 2:		SUITE 410
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27701
		BUSINESS PHONE:		440-609-9677

	MAIL ADDRESS:	
		STREET 1:		3710 SHANNON RD #51877
		STREET 2:		SUITE 410
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27717

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	POWERVERDE, INC.
		DATE OF NAME CHANGE:	20080820

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VYREX CORP
		DATE OF NAME CHANGE:	19951206
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>scwo_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:scwo="http://scwo.com/20241114"><head><title>scwo_8k.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2024-11-14to2024-11-14" id="ixv-420">0000933972</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2024-11-14to2024-11-14" format="ixt:booleanfalse" id="ixv-421">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="scwo-20241114.xsd"/></ix:references><ix:resources><xbrli:context id="From2024-11-14to2024-11-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-14</xbrli:startDate><xbrli:endDate>2024-11-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:12pt">UNITED STATES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:12pt">SECURITIES AND EXCHANGE COMMISSION </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:12pt">WASHINGTON, D.C. 20549</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:DocumentType" id="ixv-441">8-K</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>THE SECURITIES EXCHANGE ACT OF 1934</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Date of Report (date of earliest event reported): <ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen" id="ixv-442">November 14, 2024</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:left;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span style="font-size:18pt"><strong><ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:EntityRegistrantName" id="ixv-443">374WATER INC.</ix:nonNumeric></strong></span></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact Name of Registrant as Specified in Charter)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="ixv-444">Delaware</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:EntityFileNumber" id="ixv-445">001-41420</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:EntityTaxIdentificationNumber" id="ixv-446">88-0271109</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(State or Other Jurisdiction of Incorporation)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Commission File No.)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(I.R.S. Employer Identification No.)</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:27%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:EntityAddressAddressLine1" id="ixv-447">701 W Main Street</ix:nonNumeric>, <ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:EntityAddressAddressLine2" id="ixv-448">Suite 410</ix:nonNumeric> <ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:EntityAddressCityOrTown" id="ixv-449">Durham</ix:nonNumeric>, <ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:EntityAddressStateOrProvince" id="ixv-450">NC</ix:nonNumeric> <ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:EntityAddressPostalZipCode" id="ixv-451">27701</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td style="width:27%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Address of Principal Executive Offices)(Zip Code)</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">(<ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:CityAreaCode" id="ixv-452">440</ix:nonNumeric>) <ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:LocalPhoneNumber" id="ixv-453">609-9677</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Registrant&#8217;s Telephone Number, Including Area Code)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">N/A</span></strong><span style="text-decoration:underline"></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Former Name or Former Address, if Changed Since Last Report)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="ixv-454">&#9744;</ix:nonNumeric>&#160;&#160; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="ixv-455">&#9744;</ix:nonNumeric>&#160;&#160; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="ixv-456">&#9744;</ix:nonNumeric>&#160;&#160; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="ixv-457">&#9744;</ix:nonNumeric>&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Title of each class</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Trading </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Symbol(s)</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>&#160;</strong></p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name of each exchange on which </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>registered</strong></p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:Security12bTitle" id="ixv-458">Common Stock, par value $0.0001</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:TradingSymbol" id="ixv-459">SCWO</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The <ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-460">Nasdaq</ix:nonNumeric> Capital Market LLC</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging growth company&#160;&#160; <ix:nonNumeric contextRef="From2024-11-14to2024-11-14" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="ixv-461">&#9744;</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160; &#9744; </p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 1.01 Entry into a Material Definitive Agreement.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 14, 2024, 374Water Inc., a Delaware corporation (the &#8220;Company&#8221;), entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with certain investors (the &#8220;Purchasers&#8221;), pursuant to which the Company agreed to issue and sell (i) an aggregate of 9,783,496 shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, par value $0.0001 per share (&#8220;Common Stock&#8221;), and (ii) warrants (the &#8220;Warrants&#8221;) to purchase up to an aggregate of 14,675,244 shares of Common Stock in a registered direct offering (the &#8220;Offering&#8221;). The purchase price for one Share and the accompanying 1.5 Warrants was $1.25. The aggregate gross proceeds to the Company from the Offering, which closed on November 18, 2024, was approximately $12.2 million before deducting placement agent fees and other estimated offering expenses payable by the Company and excluding the proceeds, if any, from the exercise of the Warrants issued in the Offering.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The exercise price of each Warrant is $1.125. Each Warrant is immediately exercisable and will expire five years following the date of issuance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company, including for liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), other obligations of the parties and termination provisions. In the Purchase Agreement, subject to certain exceptions, the Company has agreed that neither it nor any subsidiary will (i) issue or enter into an agreement, or announce the issuance or proposed issuance of, any shares of Common Stock or Common Stock equivalents for a period of 90 days or (ii) effect or enter into an agreement to effect any issuance by the Company or any of its subsidiaries of Common Stock or Common Stock equivalents (or a combination of units thereof) involving a variable rate transaction, for a period of 180 days from the date of the Purchase Agreement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Offering was made pursuant to the Company&#8217;s registration statement on Form S-3 (File No. 333-268942), which was filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on December 22, 2022 and declared effective by the Commission on December 30, 2022, and a prospectus supplement dated November 14, 2024 filed by the Company with the Commission.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 14, 2024, the Company also entered into a placement agency agreement (the &#8220;Placement Agency Agreement&#8221;) with D. Boral Capital LLC, as the exclusive placement agent (the &#8220;Placement Agent&#8221;), in connection with the Offering. Pursuant to the terms of the Placement Agency Agreement, the Placement Agent agreed to use reasonable best efforts to arrange for the sale of the Shares and the Warrants. Pursuant to the terms of the Placement Agency Agreement, the Company paid the Placement Agent cash fees and commissions equal to: (i) five percent (5.0%) of the gross proceeds of the offering for investors introduced by the Placement Agent and (ii) two and one-half percent (2.5%) of the gross proceeds of the offering for investors introduced by the Company. The Company also agreed to reimburse the Placement Agent for expenses incurred, including disbursements of its legal counsel, in an amount not to exceed an aggregate of $75,000. The Placement Agency Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Placement Agent, including for liabilities under the Securities Act, other obligations of the parties, and termination provisions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Purchase Agreement and Placement Agency Agreement contain customary representations and warranties, covenants and indemnification provisions that the parties made to, and solely for the benefit of, each other in the context of all of the terms and conditions of such agreements and in the context of the specific relationship between the parties thereto. The provisions of the Purchase Agreement and Placement Agency Agreement, including any representations and warranties contained therein, are not for the benefit of any party other than the parties thereto (except with respect to certain representations and warranties in the Purchase Agreement that are for the benefit of the Placement Agent) and are not intended as documents for investors and the public to obtain factual information about the current state of affairs of the parties thereto. Rather, investors and the public should look to other disclosures contained in the Company&#8217;s annual, quarterly and current reports the Company may file with the Commission.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition, pursuant to certain lock-up agreements (the &#8220;Lock-Up Agreement&#8221;) that were required to be entered into as a condition to the closing of the Purchase Agreement, the Company&#8217;s officers and directors have agreed, for a period of three months from the closing date of the Offering, among other things, not to offer, sell, agree to offer or sell, solicit offers to purchase, convert, exercise, exchange, grant any call option or purchase any put option with respect to, pledge, encumber, assign, borrow or otherwise dispose of or transfer any securities of the Company or otherwise publicly disclose the intention to do so, subject to certain exceptions.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Forms of the Warrant, the Purchase Agreement and Lock-Up Agreement are filed as Exhibits 4.1, 10.1 and 10.3, respectively, to this Current Report on Form 8-K (this &#8220;Current Report&#8221;) and a copy of the Placement Agency Agreement is filed as Exhibit 10.2 to this Current Report. The foregoing summaries of the Warrant, the Purchase Agreement, the Placement Agency Agreement and the Lock-Up Agreement do not purport to be complete and are subject to, and qualified in their entirety by, reference to such exhibits. A copy of the opinion of Orrick, Herrington &amp; Sutcliffe LLP relating to the validity of the Shares and Warrants issued in the Offering and the shares of Common Stock issuable upon exercise of the Warrants is filed as Exhibit 5.1 to this Current Report.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This Current Report does not constitute an offer to sell any securities or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 7.01 Regulation FD Disclosure.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 15, 2024, the Company issued a press release announcing the Offering. A copy of the press release is furnished as Exhibit 99.1 to this Current Report and is incorporated by reference herein.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The information contained in this Item 7.01 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 9.01 Financial Statements and Exhibits.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>(d)&#160;&#160;Exhibits</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:7%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Exhibit&#160;&#160;No.</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Description</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex41.htm">4.1</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex41.htm">Form of Warrant</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex51.htm">5.1</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex51.htm">Opinion of Orrick, Herrington &amp; Sutcliffe LLP</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex101.htm">10.1*</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex101.htm">Form of Securities Purchase Agreement, dated as of November 14, 2024</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex102.htm">10.2+</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex102.htm">Placement Agency Agreement, dated as of November 14, 2024, by and between 374Water Inc. and D. Boral Capital LLC</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex103.htm">10.3</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex103.htm">Form of Lock-Up Agreement</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex51.htm">23.1</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex51.htm">Consent of Orrick, Herrington &amp; Sutcliffe LLP (included in Exhibit 5.1).</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex991.htm">99.1</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex991.htm">Press Release, dated November 15. 2024.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">104</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cover Page Interactive Data File (formatted as Inline XBRL)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">* Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Company agrees to furnish a copy of all omitted exhibits and schedules to the Commission upon its request.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">+ Certain portions of this exhibit have been omitted in compliance with Regulation S-K Item 601(b)(10)(iv) because the Company has determined that the information is not material and is the type that the Company treats as private or confidential. The Company agrees to furnish a copy of any omitted portion to the Commission upon its request.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td>&#160;</td><td colspan="2"><strong>374WATER INC.</strong></td><td/></tr><tr style="height:15px"><td style="width:50%;">&#160;</td><td style="width:5%;">&#160;</td><td style="width:35%;">&#160;</td><td style="width:10%;">&#160;</td></tr><tr style="height:15px"><td>Dated: November 18, 2024&#160;&#160;</td><td>By:</td><td style="BORDER-BOTTOM: black 1px solid;">/s/ Christian Gannon</td><td/></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Name:</p></td><td>Christian Gannon </td><td>&#160;</td></tr><tr style="height:15px"><td>&#160;</td><td>Title:</td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Chief Executive Officer</p></td><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr></tbody></table></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>scwo_ex41.htm
<DESCRIPTION>COMMON STOCK PURCHASE WARRANT
<TEXT>
<html><head><title>scwo_ex41.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 4.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FORM OF COMMON STOCK PURCHASE WARRANT</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>374WATER INC.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:50%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Warrant Shares:</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Issue Date: November 18, 2024</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Initial Exercise Date: November 18, 2024</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 1in; text-align:justify;">THIS COMMON STOCK PURCHASE WARRANT (the &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, _____________ or its assigns (the &#8220;<u>Holder</u>&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the &#8220;<u>Initial Exercise Date</u>&#8221;) and on or prior to 5:00 p.m. (New York City time) on the date that is the five year anniversary of the Issue Date of this Warrant (the &#8220;<u>Termination Date</u>&#8221;) but not thereafter, to subscribe for and purchase from 374Water Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), up to ________ shares (as subject to adjustment hereunder, the &#8220;<u>Warrant Shares</u>&#8221;) of the Company&#8217;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;"><u>Section 1</u>.&nbsp;<u>Definitions</u>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &#8220;<u>Purchase Agreement</u>&#8221;), dated November 14, 2024, among the Company and the purchasers signatory thereto.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;"><u>Section 2</u>. <u>Exercise</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">a) <u>Exercise of Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as Exhibit A (the &#8220;<u>Notice of Exercise</u>&#8221;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.<strong> </strong>No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <strong>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">b) <u>Exercise Price</u>. The exercise price per share of Common Stock under this Warrant shall be $1.125, subject to adjustment hereunder (the &#8220;<u>Exercise Price</u>&#8221;).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">c) <u>Cashless Exercise</u>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;text-align:justify;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:8%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(A) =</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&#8220;<u>Bloomberg</u>&#8221;) as of the time of the Company&#8217;s receipt of the Holder&#8217;s applicable Notice of Exercise if such Notice of Exercise is executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(B) =</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">the Exercise Price of this Warrant, as adjusted hereunder; and</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;text-align:justify;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:8%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">(X) =</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary to this Section 2(c).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">&#8220;<u>Bid Price</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if the Common Stock is not then listed or quoted on a Trading Market and if the Common Stock is listed or quoted for trading on the OTCQB Venture Market (&#8220;<u>OTCQB</u>&#8221;) or the OTCQX Best Market (&#8220;<u>OTCQX</u>&#8221;), the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (the &#8220;<u>Pink Market</u>&#8221;) operated by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company. </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.5in;text-indent:0.5in">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if the Common Stock is not then listed or quoted on a Trading Market and if the Common Stock is listed or quoted for trading on the OTCQB or the OTCQX, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company. </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 45px; text-align:justify;">d) <u>Mechanics of Exercise</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; TEXT-INDENT: 45px; text-align:justify;">i. <u>Delivery of Warrant Shares Upon Exercise</u>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the aggregate Exercise Price and the Notice of Exercise (such date, the &#8220;<u>Warrant Share Delivery Date</u>&#8221;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third (3<sup style="vertical-align:super">rd</sup>) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &#8220;<u>Standard Settlement Period</u>&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; TEXT-INDENT: 45px; text-align:justify;">ii. <u>Delivery of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; TEXT-INDENT: 45px; text-align:justify;">iii. <u>Rescission Rights</u>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.5in; TEXT-INDENT: 0.5in; text-align:justify;">iv.&nbsp; <u>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u>.&nbsp; In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than a failure that is solely due to any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.&nbsp; For example, if the Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Warrants with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.&nbsp; Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.5in; TEXT-INDENT: 45px; text-align:justify;">v. <u>No Fractional Shares or Scrip</u>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the number of Warrant Shares to be issued shall be rounded down to the nearest whole number and the Company shall pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.5in; TEXT-INDENT: 0.5in; text-align:justify;">vi.&nbsp; <u>Charges, Taxes and Expenses</u>.&nbsp; Issuance and delivery of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <u>provided</u>, <u>however</u>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto as Exhibit B, duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.&nbsp; The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.5in; TEXT-INDENT: 0.5in; text-align:justify;">vii. <u>Closing of Books.</u>&nbsp; The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 45px; text-align:justify;">e)&nbsp;<u>Holder&#8217;s Exercise Limitations</u>.&nbsp;&nbsp;&nbsp; The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with (i) the Holder&#8217;s Affiliates, (ii) any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates, and (iii) any other Persons whose beneficial ownership of the shares of Common Stock would or could be aggregated with the Holder&#8217;s for the purposes of Section 13(d) (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other&nbsp; Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.&nbsp;&nbsp; To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.&nbsp;&nbsp; In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.&nbsp; For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.&nbsp; The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be [4.99%/9.99%] of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares.&nbsp; The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply.&nbsp; Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup style="vertical-align:super">st</sup> day after such notice is delivered to the Company.&nbsp; The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;"><u>Section 3</u>. <u>Certain </u><u>Adjustments</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">a) <u>Stock Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re&#8209;classification.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">b) <u>Adjustment Upon Issuance of Common Stock</u>. If and whenever on or after the Issue Date, as long as this Warrant is outstanding, the Company issues or sells, or in accordance with this Section 3 is deemed to have issued or sold, any Common Stock or Common Stock Equivalents (including the issuance or sale of Common Stock owned or held by or for the account of the Company, but excluding (i) Common Stock deemed to have been issued or sold by the Company in connection with any Exempt Issuances and (ii) the entry into and/or issuance of shares of Common Stock in an &#8220;at-the-market&#8221; facility) for a consideration or effective consideration per share (the &#8220;<u>New Issuance Price</u>&#8221;) less than a price (the &#8220;<u>Applicable Price</u>&#8221;) equal to the Exercise Price in effect immediately prior to such issue or sale or deemed issuance or sale (the foregoing a &#8220;<u>Dilutive Issuance</u>&#8221;), then immediately after such Dilutive Issuance, the Exercise Price then in effect shall be reduced to an amount equal to the New Issuance Price. For the avoidance of doubt, (x) for the purposes of this Section 3(b), pre-funded warrants to purchase Common Stock shall be treated as Common Stock and (y) if any sale or issuance, or deemed issuance, if determined to be for a consideration per share less than the par value of a share of Common Stock, the New Issuance Price shall be deemed to be equal the par value of a share of Common Stock. For purposes of determining the adjusted Exercise Price under this Section 3(b), the following shall be applicable:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 0in; text-align:justify;">(i) <u>Issuance of Options</u>. If the Company in any manner grants or sells any Options and the lowest price per share for which one share of Common Stock is issuable upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the granting or sale of such Option for such price per share. &#8220;<u>Options</u>&#8221; means any rights, warrants or options to subscribe for or purchase (i) Common Stock or (ii) Convertible Securities. &#8220;<u>Convertible Securities</u>&#8221; means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable for Common Stock. For purposes of this Section 3(b)(i), the &#8220;lowest price per share for which one share of Common Stock is issuable upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option&#8221; shall be equal to the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share of Common Stock upon the granting or sale of the Option, upon exercise of the Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option less any consideration paid or payable by the Company with respect to such one share of Common Stock upon the granting or sale of such Option, upon exercise of such Option and upon conversion exercise or exchange of any Convertible Security issuable upon exercise of such Option. No further adjustment of the Exercise Price shall be made upon the actual issuance of such Common Stock or of such Convertible Securities upon the exercise of such Options or upon the actual issuance of such Common Stock upon conversion, exercise or exchange of such Convertible Securities.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 0in; text-align:justify;">(ii) <u>Issuance of Convertible Securities</u>. If the Company in any manner issues or sells any Convertible Securities and the lowest price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale of such Convertible Securities for such price per share. For the purposes of this Section 3(b)(ii), the &#8220;lowest price per share for which one share of Common Stock is issuable upon the conversion, exercise or exchange thereof&#8221; shall be equal to the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one share of Common Stock upon the issuance or sale of the Convertible Security and upon conversion, exercise or exchange of such Convertible Security less any consideration paid or payable by the Company with respect to such one share of Common Stock upon the issuance or sale of such Convertible Security and upon conversion, exercise or exchange of such Convertible Security. No further adjustment of the Exercise Price shall be made upon the actual issuance of such Common Stock upon conversion, exercise or exchange of such Convertible Securities, and if any such issue or sale of such Convertible Securities is made upon exercise of any Options for which adjustment of this Warrant has been or is to be made pursuant to other provisions of this Section 3(a), no further adjustment of the Exercise Price shall be made by reason of such issue or sale.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;">(iii) <u>Change in Option Price or Rate of Conversion.</u> If the purchase price provided for in any Options, the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities are convertible into or exercisable or exchangeable for Common Stock increases or decreases at any time, the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price, which would have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes of this Section 3(b)(iii), if the terms of any Option or Convertible Security that was outstanding as of the Issue Date are increased or decreased in the manner described in the immediately preceding sentence, then such Option or Convertible Security and the Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 3(b) shall be made if such adjustment would result in an increase of the Exercise Price then in effect.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 90px">(iv)&nbsp;<u>Calculation of Consideration Received</u>. In case any Option is issued in connection with the issue or sale of other securities of the Company, together comprising one integrated transaction, (x) the Options will be deemed to have been issued for the Option Value of the Options and (y) the other securities issued or sold in such integrated transaction shall be deemed to have been issued or sold for the difference of (I) the aggregate consideration received by the Company less any consideration paid or payable by the Company pursuant to the terms of such other securities of the Company, less (II) the Option Value of such Options. &#8220;<u>Option Value</u>&#8221; means the value of an Option based on the Black and Scholes Option Pricing Model obtained from the "OV" function on Bloomberg determined as of (A) the Trading Day prior to the public announcement of the issuance of the applicable Option, if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, for pricing purposes and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of the applicable Option as of the applicable date of determination, (ii) an expected volatility equal to the 100 day volatility obtained from the HVT function on Bloomberg as of (A) the Trading Day immediately following the public announcement of the applicable Option if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, (iii) the underlying price per share used in such calculation shall be the highest VWAP of the Common Stock during the period beginning on the Trading Day prior to the execution of definitive documentation relating to the issuance of the applicable Option and ending on (A) the Trading Day immediately following the public announcement of such issuance, if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, (iv) a zero cost of borrow, (v) a remaining option time equal to the time between (A) the Trading Day immediately following the public announcement of such issuance, if the issuance of such Option is publicly announced or (B) the Trading Day immediately following the issuance of the applicable Option if the issuance of such Option is not publicly announced, and the remaining term of the applicable Option as of the applicable date of determination and (vi) a 360 day annualization factor. If any Common Stock, Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the cash consideration received therefor will be deemed to be the net amount received by the Company therefor. If any Common Stock, Options or Convertible Securities are issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the fair value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration received by the Company will be the Closing Sale Price of such publicly traded securities on the date of receipt of such publicly traded securities. If any Common Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such Common Stock, Options or Convertible Securities, as the case may be. The fair value of any consideration other than cash or publicly traded securities will be determined jointly by the Company and the Required Holders. If such parties are unable to reach agreement within ten (10) days after the occurrence of an event requiring valuation (the &#8220;<u>Valuation Event</u>&#8221;), the fair value of such consideration will be determined within five (5) Business Days after the tenth (10<sup style="vertical-align:super">th</sup>) day following the Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Required Holders. The determination of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company. Notwithstanding anything to the contrary contained herein, if a calculation pursuant to this Section 2(b)(iv) would result in an Exercise Price that is lower than the par value of the Common Stock, then the Exercise Price shall be deemed to equal the par value of the Common Stock. &#8220;Required Holders&#8221; shall mean holders of a majority of the Warrants issued under the Purchase Agreement and the other similar agreements entered into contemporaneously therewith.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 0in; text-align:justify;">(v) <u>Record Date</u>. If the Company takes a record of the holders of Common Stock for the purpose of entitling them (A) to receive a dividend or other distribution payable in Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the issue or sale of the Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase, as the case may be.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 0in; text-align:justify;">(vi) <u>No Readjustment</u>. For the avoidance of doubt, in the event that following the consummation of a Dilutive Issuance and the Exercise Price has been adjusted pursuant to this Section 3(b) and the Dilutive Issuance that triggered such adjustment is unwound, cancelled or expires after the fact for any reason, the Exercise Price will not be readjusted to the Exercise Price that would have been in effect if such Dilutive Issuance had not occurred or been consummated.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">c) <u>Subsequent Rights Offerings</u>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all (or substantially all) of the record holders of any class of shares of Common Stock (the &#8220;<u>Purchase Rights</u>&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<u>provided</u>, <u>however</u>, that, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">d) <u>Pro Rata Distributions</u>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;<u>Distribution</u>&#8221;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<u>provided</u>, <u>however</u>, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">e) <u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets, taken as a whole, in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &#8220;<u>Fundamental Transaction</u>&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#8220;<u>Alternate Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, Holder shall only be entitled to receive from the Company or any Successor Entity, as of the date of the consummation of such Fundamental Transaction, the same type or form of consideration (and in the same proportion), valued at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &#8220;<u>Black Scholes Value</u>&#8221; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg, L.P. (&#8220;Bloomberg&#8221;) determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&#8217;s request pursuant to this Section 3(e) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&#8217;s election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;<u>Successor Entity</u>&#8221;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &#8220;Company&#8221; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &#8220;Company&#8221; shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(e) regardless of whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">f) <u>Share Combination Event Adjustment</u>. In addition to the adjustments set forth in this Section 3, if at any time on or after the Issuance Date there occurs any share split, reverse share split, share dividend, share combination recapitalization or other similar transaction involving the Common Stock (each, a &#8220;<u>Share Combination Event</u>&#8221;, and such date on which the Share Combination Event is effected, the &#8220;<u>Share Combination Event Date</u>&#8221;) and the lowest daily VWAP of the Common Stock during the period commencing on the Trading Day immediately following the applicable Share Combination Event Date and ending on the fifth (5<sup style="vertical-align:super">th</sup>) Trading Day immediately following the applicable Share Combination Event Date (the &#8220;<u>Event Market Price</u>&#8221;) (provided if the Share Combination Event is effective prior to the opening of trading on the Trading Market, then, commencing on the Share Combination Event Date and ending on the fourth (4<sup style="vertical-align:super">th</sup>) Trading Day immediately following the applicable Share Combination Event Date (such period, the &#8220;<u>Share Combination Adjustment Period</u>&#8221;)) is less than the Exercise Price then in effect (after giving effect to the adjustment in Section 3(a) above), then, at the close of trading on the Trading Market on the last day of the Share Combination Adjustment Period, the Exercise Price then in effect on such 5<sup style="vertical-align:super">th</sup> Trading Day shall be reduced (but in no event increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in this Section 3(f) would otherwise result in an increase in the Exercise Price hereunder, no adjustment shall be made, and if this Warrant is exercised, on any date on which the Holder delivers an Exercise Notice to the Company (an &#8220;<u>Exercise Date</u>&#8221;) during the Share Combination Adjustment Period, solely with respect to such portion of this Warrant exercised on such applicable Exercise Date, such applicable Share Combination Adjustment Period shall be deemed to have ended on, and include, the Trading Day immediately prior to such Exercise Date and the Event Market Price on such applicable Exercise Date will be the lowest daily VWAP of the Common Stock immediately following the Share Combination Event Date and ending on, and including the Trading Day immediately prior to such Exercise Date. Any adjustment to the Exercise Price pursuant to this Section 3(f) shall be effective retroactively to the Share Combination Event Date.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">g) <u>Calculations</u>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">h) <u>Notice to Holder</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.5in; TEXT-INDENT: 0.5in; text-align:justify;">i. <u>Adjustment to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment. For purposes of clarification, whether or not the Company provides any such notice, each Holder shall only be required to pay the adjusted Exercise Price with respect to such exercise, regardless of whether a Holder accurately refers to such price in any Notice of Exercise If the aggregate Exercise Price paid by the Holder exceeds the amount that should have been paid based on the adjusted Exercise Price, the Company shall promptly return any excess aggregate Exercise Price to the Holder.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">14</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1.5in; TEXT-INDENT: 0.5in; text-align:justify;">ii.&nbsp;<u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any Fundamental Transaction, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.&nbsp; To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.&nbsp; The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">15</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;"><u>Section 4</u>. <u>Transfer of Warrant</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">a) <u>Transferability</u>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">b) <u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">c) <u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;<u>Warrant Register</u>&#8221;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;"><u>Section 5</u>. <u>Miscellaneous</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">a) <u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &#8220;cashless exercise&#8221; pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">b) <u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">16</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">c) <u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">d) <u>Authorized Shares</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 1in; text-align:justify;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 0.5in; text-align:justify;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">17</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 1in; TEXT-INDENT: 0.5in; text-align:justify;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">e) <u>Jurisdiction</u>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">f) <u>Restrictions</u>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">g) <u>Nonwaiver and Expenses</u>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">h) <u>Notices</u>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">i) <u>Limitation of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">j) <u>Remedies</u>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">18</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">k) <u>Successors and Assigns</u>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">l) <u>Amendment</u>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder of this Warrant, on the other hand.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">m) <u>Severability</u>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; TEXT-INDENT: 0.5in; text-align:justify;">n) <u>Headings</u>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">********************</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(Signature Page Follows)</em></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">19</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 1in; text-align:justify;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td>&nbsp;</td> <td colspan="2"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>374WATER INC.</strong></p></td> <td></td></tr> <tr style="height:15px"> <td style="width:50%;">&nbsp;</td> <td style="width:3%;">&nbsp;</td> <td style="width:35%;">&nbsp;</td> <td style="width:12%;">&nbsp;</td></tr> <tr style="height:15px"> <td></td> <td>By:</td> <td style="BORDER-BOTTOM: black 1px solid;"></td> <td></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Name:</p></td> <td>&nbsp;</td></tr> <tr style="height:15px"> <td>&nbsp;</td> <td></td> <td>Title:</td> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">20</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT A</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>NOTICE OF EXERCISE</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">To:</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">374WATER INC.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(2) Payment shall take the form of (check applicable box):</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">[ ] in lawful money of the United States; or</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">[ ] if permitted, the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">_______________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Warrant Shares shall be delivered to the following DWAC Account Number:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">_______________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">_______________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 135px; text-align:justify;">_______________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">[SIGNATURE OF HOLDER]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name of Investing Entity: ________________________________________________________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Signature of Authorized Signatory of Investing Entity</em>: _________________________________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name of Authorized Signatory: ___________________________________________________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Title of Authorized Signatory: ____________________________________________________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Date: ________________________________________________________________________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT B</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">ASSIGNMENT FORM</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 15px; text-align:justify;"><em>(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</em></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 15px; text-align:justify;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:45%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name:</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:45%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="width:10%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(Please Print)</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Address:</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(Please Print)</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Phone Number:</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Email Address: </p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dated: _______________ __, ______</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Holder&#8217;s Signature:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Holder&#8217;s Address:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u></p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>scwo_ex51.htm
<DESCRIPTION>OPINION
<TEXT>
<html><head><title>scwo_ex51.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT&nbsp;5.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:70%;"></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:left;margin:0px"><img src="scwo_ex51img1.jpg"></p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">November 18, 2024</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;text-align:left;margin:0px">374Water Inc.</p> <p style="font-size:10pt;font-family:times new roman;text-align:left;margin:0px 0px 0px 0in">701 W Main Street, Suite 410 </p> <p style="font-size:10pt;font-family:times new roman;text-align:left;margin:0px 0px 0px 0in">Durham, NC&nbsp; 27701</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:left;margin:0px 0px 0px 0in"><strong>Orrick, Herrington &amp; Sutcliffe LLP</strong></p> <p style="font-size:10pt;font-family:times new roman;text-align:left;margin:0px">The Orrick Building</p> <p style="font-size:10pt;font-family:times new roman;text-align:left;margin:0px">405 Howard Street</p> <p style="font-size:10pt;font-family:times new roman;text-align:left;margin:0px">San Francisco, CA&nbsp; 94105</p> <p style="font-size:10pt;font-family:times new roman;text-align:left;margin:0px">+1-415-773-5700</p> <p style="font-size:10pt;font-family:times new roman;text-align:left;margin:0px 0px 0px 0in"><strong>orrick.com</strong></p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Re:</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Offering of Common Stock and Warrants</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Ladies and Gentlemen:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We have acted as counsel for 374Water Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), in connection with the offer and sale by the Company of (i) 9,783,496 shares (the &#8220;<u>Shares</u>&#8221;) of the Company&#8217;s common stock, $0.0001 par value per share (the &#8220;<u>Common Stock</u>&#8221;) and (ii) warrants (the &#8220;<u>Warrants</u>&#8221; and, together with the Shares, the &#8220;<u>Securities</u>&#8221;) to purchase up to an aggregate of 14,675,244 shares of Common Stock, pursuant to the Company&#8217;s registration statement on Form S-3 (Registration Statement No. 333-268942) (the &#8220;<u>Registration Statement</u>&#8221;), filed with the Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<u>Act</u>&#8221;), the prospectus dated December 30, 2022 (the &#8220;<u>Base Prospectus</u>&#8221;), and the prospectus supplement relating to the Shares, the Warrants and the shares of Common Stock issuable upon exercise of the Warrants (the &#8220;<u>Warrant Shares</u>&#8221;), dated November 14, 2024, filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations of the Act (the &#8220;<u>Prospectus Supplement</u>&#8221;). The Base Prospectus and the Prospectus Supplement are collectively referred to as the &#8220;<u>Prospectus</u>.&#8221; The Securities are to be sold by the Company in the manner described in the Registration Statement and the Prospectus. The Company is filing this opinion letter with the Commission on a Current Report on Form 8-K (the &#8220;<u>Current Report</u>&#8221;).</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In connection with rendering the opinions set forth below, we have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of (i) the Amended and Restated Certificate of Incorporation of the Company, (ii) the Amended and Restated Bylaws of the Company, (iii) certain resolutions of the Board of Directors of the Company or a duly authorized committee thereof relating to the issuance, sale and registration of the Securities and Warrant Shares, (iv) the Registration Statement, (v) the Prospectus and (vi) such corporate records of the Company, certificates of public officials, officers of the Company and other persons, and such other documents, agreements and instruments as we have deemed relevant and necessary or appropriate as a basis for the opinion set forth below.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">In our examination, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies, and the authenticity of the originals of such copies. In making our examination of documents executed or to be executed, we have assumed that the parties thereto, other than the Company, had or will have the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and the execution and delivery by such parties of such documents and the validity and binding effect thereof on such parties. We have further assumed the sufficiency of any consideration for the obligations of each of the parties under the documents covered by this opinion letter to which it is a party, and that there are no modifications, amendments or supplements to any of the documents covered by this opinion letter other than as referenced herein. As to any facts material to the opinions expressed herein that we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives of the Company and others and of public officials.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">November 18, 2024</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Page 2</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We have also assumed that (i) any securities issuable upon conversion, exchange, or exercise of any Securities being offered or issued will be duly authorized, created, and, if appropriate, reserved for issuance upon such conversion, exchange, or exercise; and (ii) after the issuance of any securities offered pursuant to the Registration Statement, the total number of issued shares of Common Stock together with the total number of shares of such stock issuable upon the exercise, exchange, conversion, or settlement, as the case may be, of any exercisable, exchangeable or convertible security then outstanding, will not exceed the total number of authorized shares of Common Stock available for issuance under the Company&#8217;s certificate of incorporation as then in effect.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">With respect to the Warrants and the Warrant Shares, we express no opinion to the extent that, notwithstanding the Company&#8217;s current reservation of shares of Common Stock, future issuances of securities of the Company, including the Warrant Shares, and/or antidilution adjustments to outstanding securities of the Company, including the Warrants, may cause the Warrants to be exercisable for more shares of Common Stock than the number that then remain authorized but unissued. Further, we have assumed the Exercise Price (as defined in the Warrants) will not be adjusted to an amount below the par value per share of the shares of Common Stock.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Based upon the foregoing and subject to the limitations, qualifications and assumptions set forth herein, we are of the opinion that:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; text-align:justify;">1. The Shares have been duly authorized and, upon issuance, delivery and payment therefor in the manner contemplated by the Registration Statement and the Prospectus, will be validly issued, fully paid and non-assessable;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; text-align:justify;">2. The Warrant Shares, when issued and paid for upon exercise of the Warrants in accordance with the terms of the Warrants, will be validly issued, fully paid and non-assessable; and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.5in; text-align:justify;">3. When the Warrants have been duly executed and delivered to the purchaser thereof against payment therefor and have been duly issued and sold as contemplated in the Registration Statement, the Warrants will constitute the valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our opinion that any document is valid, binding or enforceable in accordance with its terms is subject to: (a) limitations imposed by bankruptcy, insolvency, receivership, conservatorship, reorganization, fraudulent conveyance, arrangement, moratorium or other laws relating to or affecting the enforcement of creditors&#8217; rights generally; (b) rights to indemnification and contribution which may be limited by applicable law or equitable principles or otherwise unenforceable as against public policy; (c) the unenforceability under certain circumstances of provisions imposing liquidated damages, penalties, forfeiture, late payment charges, or an increase in interest rate upon delinquency in payment or the occurrence of any event of default; (d) applicable laws limiting unreasonable restraints on the alienation of property; and (e) general principles of equity including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing, and the possible unavailability of specific performance or injunctive relief, regardless of whether such enforceability is considered in a proceeding in equity or at law. We also express no opinion as to the enforceability of choice of law or selection of forum provisions in the documents described herein.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">November 18, 2024</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Page 3</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We express no opinion as to any provision of the Warrants that: (i) provides for economic remedies to the extent such provisions may constitute unlawful penalties, (ii) relates to advance waivers of claims, defenses, rights granted by law, or notice, opportunity for hearing, evidentiary requirements, statutes of limitations, trial by jury, or procedural rights, (iii) restricts non-written modifications and waivers, (iv) provides for the payment of legal and other professional fees where such payment is contrary to law or public policy, (v) relates to exclusivity, election or accumulation of rights or remedies, (vi) authorizes or validates conclusive or discretionary determinations, or (vii) provides that provisions of the Warrants are severable to the extent an essential part of the agreed exchange is determined to be invalid and unenforceable.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Our opinions herein are limited to the General Corporation Law of the State of Delaware, the laws of the State of New York, and the federal laws of the United States of America. This opinion letter is limited to such laws as are in effect on the date hereof. Without limitation, no opinion is expressed herein with respect to the qualification of the Securities and the Warrant Shares under the securities or blue sky laws of any state or any foreign jurisdiction. We hereby consent to the reference to our firm under the heading &#8220;Legal Matters&#8221; in the Prospectus Supplement and to the filing of this opinion letter as an exhibit to the Current Report and its incorporation by reference into the Registration Statement. By giving this consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Act and the rules and regulations promulgated thereunder.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Very truly yours,</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">/s/ ORRICK, HERRINGTON &amp; SUTCLIFFE LLP&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ORRICK, HERRINGTON &amp; SUTCLIFFE LLP</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>scwo_ex101.htm
<DESCRIPTION>SECURITIES PURCHASE AGREEMENT
<TEXT>
<html><head><title>scwo_ex101.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>FORM OF SECURITIES PURCHASE AGREEMENT</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">This Securities Purchase Agreement (this &#8220;<u>Agreement</u>&#8221;) is dated as of November 14, 2024 between 374Water Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &#8220;<u>Purchaser</u>&#8221; and collectively the &#8220;<u>Purchasers</u>&#8221;).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ARTICLE I.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">DEFINITIONS</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">1.1 <u>Definitions.</u> In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Acquiring Person</u>&#8221; shall have the meaning ascribed to such term in Section 4.5.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Action</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(j).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Affiliate</u>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Board of Directors</u>&#8221; means the board of directors of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Business Day</u>&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; <u>provided</u>, <u>however</u>, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;, &#8220;non-essential employee&#8221; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Closing</u>&#8221; means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Closing Date</u>&#8221; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers&#8217; obligations to pay the Subscription Amount and (ii) the Company&#8217;s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the first (1<sup style="vertical-align:super">st</sup>) Trading Day following the date hereof.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Commission</u>&#8221; means the United States Securities and Exchange Commission.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Common Stock</u>&#8221; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Common Stock Equivalents</u>&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Common Warrants</u>&#8221; means, collectively, the Common Stock Purchase Warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which Common Warrants shall be exercisable immediately upon issuance and have a term equal to five (5) years, in the form of Exhibit A attached hereto.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Company Counsel</u>&#8221; means Orrick, Herrington &amp; Sutcliffe LLP, 405 Howard Street, San Francisco, California 94105.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Disclosure Schedules</u>&#8221; means the Disclosure Schedules of the Company delivered concurrently herewith.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Disclosure Time</u>&#8221; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Evaluation Date</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(s).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Exempt Issuance</u>&#8221; means the issuance of (a) Common Stock or options or other equity awards to employees, officers, consultants, members of its scientific advisory board or directors of the Company pursuant to any share or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities issued upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with share splits or combinations) or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the non-employee members of the Board of Directors, provided that such securities are issued as &#8220;restricted securities&#8221; (as defined in Rule 144) and carry no registration rights that require the filing of any registration statement in connection therewith during the prohibition period in Section 4.12(a) herein and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>FCPA</u>&#8221; means the Foreign Corrupt Practices Act of 1977, as amended.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>GAAP</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(h).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Indebtedness</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(aa).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Intellectual Property Rights</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(p).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Liens</u>&#8221; means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Lock-Up Agreement</u>&#8221; means, collectively, the Lock-Up Agreements, dated as of the date hereof, by and among the Company and the directors and officers of the Company, in the form of <u>Exhibit B</u> attached hereto.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Material Adverse Effect</u>&#8221; shall have the meaning assigned to such term in Section 3.1(b).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Material Permits</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(n).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Per Share Purchase Price</u>&#8221; equals $1.25, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Person</u>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Placement Agent</u>&#8221; means D. Boral Capital LLC.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Proceeding</u>&#8221; means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Prospectus</u>&#8221; means the final base prospectus filed for the Registration Statement, including all information, documents and exhibits filed with or incorporated by reference into such prospectus.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Prospectus Supplement</u>&#8221; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act, including all information, documents and exhibits filed with or incorporated by reference into such prospectus supplement, that is filed with the Commission and delivered by the Company to each Purchaser at the Closing.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Purchaser Party</u>&#8221; shall have the meaning ascribed to such term in Section 4.8.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Registration Statement</u>&#8221; means the effective registration statement on Form S-3 filed with the Commission (File No. 333-268942) which registers the issuance and sale of the Shares, the Common Warrants and the Warrant Shares to the Purchasers.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Required Approvals</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(e).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Rule 144</u>&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Rule 424</u>&#8221; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>SEC Reports</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(h).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Securities</u>&#8221; means the Shares, the Common Warrants and the Warrant Shares.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Shares</u>&#8221; means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Short Sales</u>&#8221; means all &#8220;short sales&#8221; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include locating and/or borrowing Common Stock).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Subscription Amount</u>&#8221; means, as to each Purchaser, the aggregate amount to be paid for Shares and Common Warrants, as the case may be, purchased hereunder as specified below such Purchaser&#8217;s name on the signature page of this Agreement and next to the heading &#8220;Subscription Amount,&#8221; in United States dollars and in immediately available funds.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Subsidiary</u>&#8221; means any subsidiary as defined in Rule 405 under the Securities Act and listed in Exhibit 21 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Trading Day</u>&#8221; means a day on which the principal Trading Market is open for trading.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Trading Market</u>&#8221; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Transaction Documents</u>&#8221; means this Agreement, the Common Warrants, the Placement Agent Agreement, the Lock-Up Agreements and all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Transfer Agent</u>&#8221; means Direct Transfer, LLC, whose address One Glenwood Avenue, Suite 1001, Raleigh, North Carolina 27603 , the current transfer agent of the Company and any successor transfer agent of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Variable Rate Transaction</u>&#8221; shall have the meaning ascribed to such term in Section 4.12(b).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&#8220;<u>Warrant Shares</u>&#8221; means the shares of Common Stock issuable upon exercise of the Common Warrants.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ARTICLE II.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">PURCHASE AND SALE</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">2.1 <u>Closing.</u> On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $12,229,370 of Shares and Common Warrants. Each Purchaser&#8217;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for &#8220;Delivery Versus Payment&#8221; settlement with the Placement Agent. The Company shall deliver to each Purchaser its respective Shares and Common Warrants as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing.&nbsp;&nbsp;Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall take place remotely by electronic transfer of the Closing documentation.&nbsp;&nbsp;Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via &#8220;Delivery Versus Payment&#8221; (&#8220;DVP&#8221;)<em> </em>(i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&#8217; names and addresses and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company).&nbsp;Notwithstanding anything herein to the contrary, if at any time on or after the time of execution of this Agreement by the Company and an applicable Purchaser through the Closing (the &#8220;Pre-Settlement Period&#8221;), such Purchaser sells to any Person all, or any portion, of any Shares to be issued hereunder to such Purchaser at the Closing (collectively, the &#8220;Pre-Settlement Shares&#8221;), such Person shall, automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to be a Purchaser under this Agreement unconditionally bound to purchase, and the Company shall be deemed unconditionally bound to sell, such Pre-Settlement Shares to such Person at the Closing; provided, that the Company shall not be required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company&#8217;s receipt of the Subscription Amount for such Pre-Settlement Shares hereunder; provided, further, that the Company hereby acknowledges and agrees that the foregoing shall not constitute a representation or covenant by such Purchaser as to whether or not such Purchaser will elect to sell any Pre-Settlement Shares during the Pre-Settlement Period. The decision to sell any Shares will be made in the sole discretion of such Purchaser from time to time, including during the Pre-Settlement Period.&nbsp;Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined in the Common Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the Closing Date, which may be delivered at any time after the time of execution of this Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the Common Warrants) for purposes hereunder.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">2.2 <u>Deliveries.</u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(a) On or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">(i) this Agreement duly executed by the Company;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">(ii) a legal opinion of Company Counsel, substantially in form and substance reasonably satisfactory to the Placement Agent and each Purchaser;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">(iii) a certificate evidencing the formation and good standing of the Company issued by each of the Secretary of State of Delaware and the Secretary of State of North Carolina as of a date within three (3) days of the Closing Date.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">(iv) a certificate, in the form acceptable to the Placement Agent, executed by the Secretary of the Company and dated as of the Closing Date, certifying the authenticity of (i) resolutions of the Company&#8217;s board of directors approving the transactions contemplated hereby and the execution of the Transaction Documents, in a form reasonably acceptable to the Placement Agent, (ii) the Certificate of Incorporation of the Company and (iii) the Bylaws of the Company, each as in effect at the Closing and attached to such certificate.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">(v) a certificate, in the form acceptable to the Placement Agent, executed by the Chief Financial Officer of the Company and dated as of the Closing Date;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">(vi) subject to the fifth sentence of Section 2.1, the Company shall have provided each Purchaser with the Company&#8217;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:135px">(vii) subject to the fifth sentence of Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver Shares equal to such Purchaser&#8217;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser to be held in an account established with the Transfer Agent;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">(viii) a Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 150% of such Purchaser&#8217;s Shares, with an exercise price equal to $1.125, subject to adjustment therein;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">(ix) on the date hereof, the duly executed Lock-Up Agreements; and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">(x) the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(b) On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; TEXT-INDENT: 45px; text-align:justify;">(i) this Agreement duly executed by such Purchaser; and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; TEXT-INDENT: 45px; text-align:justify;">(ii) such Purchaser&#8217;s Subscription Amount, which shall be made available for DVP settlement with the Company or its designee.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">2.3 <u>Closing Conditions.</u> </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(a) The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; TEXT-INDENT: 45px; text-align:justify;">(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless such representation or warranty is as of a specific date therein in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date); </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; TEXT-INDENT: 45px; text-align:justify;">(ii) all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed in all material respects; and</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; TEXT-INDENT: 45px; text-align:justify;">(iii) the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(b) The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; TEXT-INDENT: 45px; text-align:justify;">(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless such representation or warranty is as of a specific date therein in which case they shall be accurate in all respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 90px; text-align:justify;">(ii) all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 45px;text-indent:90px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; TEXT-INDENT: 45px; text-align:justify;">(iii) the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; TEXT-INDENT: 45px; text-align:justify;">(iv) there shall have been no Material Adverse Effect with respect to the Company since the date hereof; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; TEXT-INDENT: 45px; text-align:justify;">(v) the Company shall have filed an additional listing application with the principal Trading Market with respect to the Shares and Warrant Shares; and </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 90px; TEXT-INDENT: 45px; text-align:justify;">(vi) from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&#8217;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ARTICLE III.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">REPRESENTATIONS AND WARRANTIES</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">3.1 <u>Representations and Warranties of the Company.</u> Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(a) <u>Subsidiaries.</u> All of the direct and indirect subsidiaries of the Company are set forth in the Company&#8217;s SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(b) <u>Organization and Qualification</u>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&#8217;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &#8220;<u>Material Adverse Effect</u>&#8221;) and, to the knowledge of the Company, no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(c) <u>Authorization; Enforcement</u>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company&#8217;s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(d) <u>No Conflicts</u>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&#8217;s or any Subsidiary&#8217;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(e) <u>Filings, Consents and Approvals</u>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local, foreign or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) the notice and/or application(s) to and approvals by each applicable Trading Market for the issuance and sale of the Securities and the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, and (iv) such filings as are required to be made under applicable state securities laws (collectively, the &#8220;<u>Required Approvals</u>&#8221;).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(f) <u>Issuance of the Securities; Registration</u>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Warrant Shares, when issued in accordance with the terms of the Common Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Common Warrants. The Company prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on December 30, 2022 (the &#8220;<u>Effective Date</u>&#8221;), including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that this representation and warranty does not apply to statements in or omissions from any Prospectus Supplement made in reliance upon and in conformity with information relating to the Purchasers furnished to the Company in writing by or on behalf of the Purchasers expressly for use therein. The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The Company, if required by the rules and regulations of the Commission, shall file the Prospectus Supplement with the Commission pursuant to Rule 424(b).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(g) <u>Capitalization</u>. As of the date hereof, the authorized capital stock of the Company consists of 200,000,000 shares of common stock, par value $0.0001 per share, and 50,000,000 shares of preferred stock, par value $0.0001 per share. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&#8217;s stock option plans, the issuance of Common Stock to employees pursuant to the Company&#8217;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities and as set forth on <u>Schedule 3.1(g)</u>, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. Except as set forth on <u>Schedule 3.1(g)</u>, the issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. Except as set forth on <u>Schedule 3.1(g)</u>, there are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or &#8220;phantom stock&#8221; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all applicable federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&#8217;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&#8217;s stockholders.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(h) <u>SEC Reports; Financial Statements</u>. Except as set forth in <u>Schedule 3.1(h)</u>, the Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the 12 months preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus Supplement, being collectively referred to herein as the &#8220;<u>SEC Reports</u>&#8221;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&#8220;<u>GAAP</u>&#8221;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(i) <u>Material Changes; Undisclosed Events, Liabilities or Developments</u>. Since the date of the latest audited financial statements included within the SEC Reports, except as set forth on <u>Schedule 3.1(i)</u>, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&#8217;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not materially altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <u>Schedule 3.1(i)</u>, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(j) <u>Litigation</u>. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &#8220;<u>Action</u>&#8221;) that could have or reasonably be expected to result in a Material Adverse Effect. There is no Action that (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(k) <u>Labor Relations</u>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&#8217;s or its Subsidiaries&#8217; employees is a member of a union that relates to such employee&#8217;s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(l) <u>Compliance</u>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(m) <u>Reserved.</u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(n) <u>Regulatory Permits</u>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&#8220;<u>Material Permits</u>&#8221;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(o) <u>Title to Assets</u>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state, foreign or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, with such exceptions as are not material and do not materially interfere with the use made or proposed to be made of such real property, improvements, equipment or personal property by the Company or such subsidiary.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(p) <u>Intellectual Property</u>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as currently conducted or as currently proposed to be conducted as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the &#8220;<u>Intellectual Property Rights</u>&#8221;). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has no knowledge of facts that would preclude it from having valid license rights or clear title to the Intellectual Property Rights. The Company has no knowledge that it lacks or will be unable to obtain any rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(q) <u>Reserved.</u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(r) <u>Transactions With Affiliates and Employees</u>. Except as set forth on <u>Schedule 3.1(r)</u>, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(s) <u>Sarbanes-Oxley; Internal Accounting Controls</u>. The Company and the Subsidiaries are in compliance in all material respects with any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof and as of the Closing Date, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&#8217;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms. The Company&#8217;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &#8220;<u>Evaluation Date</u>&#8221;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(t) <u>Certain Fees</u>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&#8217;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(u) <u>Investment Company</u>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an &#8220;investment company&#8221; subject to registration under the Investment Company Act of 1940, as amended.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(v) <u>Registration Rights</u>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(w) <u>Listing and Maintenance Requirements</u>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(x) <u>Application of Takeover Protections</u>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti&#8209;takeover provision under the Company&#8217;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&#8217;s issuance of the Securities and the Purchasers&#8217; ownership of the Securities.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(y) <u>Disclosure</u>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, taken as a whole, is true and correct in all material respects and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(z) <u>No Integrated Offering</u>. Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(aa) <u>Solvency</u>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&#8217;s assets exceeds the amount that will be required to be paid on or in respect of the Company&#8217;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&#8217;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. <u>Schedule 3.1(aa)</u> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &#8220;<u>Indebtedness</u>&#8221; means (x) any liabilities for borrowed money or amounts owed in excess of $100,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&#8217;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(bb) <u>Tax Status</u>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(cc) <u>Foreign Corrupt Practices</u>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(dd) <u>Accountants</u>. The Company&#8217;s independent registered public accounting firm is Cherry Bekaert LLP. To the knowledge and belief of the Company, such accounting firm is a registered public accounting firm as required by the Exchange Act. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(ee) <u>Acknowledgment Regarding Purchasers&#8217; Purchase of Securities</u>. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm&#8217;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&#8217; purchase of the Securities. The Company further represents to each Purchaser that the Company&#8217;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(ff) <u>Acknowledgment Regarding Purchaser&#8217;s Trading Activity</u>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2 (f) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &#8220;derivative&#8221; securities based on securities issued by the Company or to hold the Securities for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &#8220;derivative&#8221; transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&#8217;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &#8220;derivative&#8221; transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &#8220;short&#8221; position in the Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&#8217;s length counter-party in any &#8220;derivative&#8221; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders' equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">14</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(gg) <u>Regulation M Compliance</u>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(hh) <u>[RESERVED]</u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(ii) <u>Stock Option Plans</u>. Each stock option granted by the Company under the Company&#8217;s stock option plan was granted (i) in accordance with the terms of the Company&#8217;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&#8217;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(jj) <u>Cybersecurity</u>. (i)(x) To the Company&#8217;s knowledge, there has been no material security breach or other material compromise of or relating to any of the Company&#8217;s or any Subsidiary&#8217;s information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &#8220;<u>IT Systems and Data</u>&#8221;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; and (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(kk) <u>Office of Foreign Assets Control</u>. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<u>OFAC</u>&#8221;).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(ll) <u>U.S. Real Property Holding Corporation</u>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&#8217;s request.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(mm) <u>Bank Holding Company Act</u>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &#8220;<u>BHCA</u>&#8221;) and to regulation by the Board of Governors of the Federal Reserve System (the &#8220;<u>Federal Reserve</u>&#8221;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five (25%) percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">15</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(nn) <u>Money Laundering</u>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in all material respects with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &#8220;<u>Money Laundering Laws</u>&#8221;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">3.2 <u>Representations and Warranties of the Purchasers.</u> Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(a) <u>Organization; Authority.</u> Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(b) <u>Understandings or Arrangements.</u> Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business. Such Purchaser is acquiring such Securities as principal for his, her, or its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&#8217;s right to sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal and state securities laws). </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(c) <u>Purchaser Status</u>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Common Warrants, it will either be an &#8220;accredited investor&#8221; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12) or (a)(13) under the Securities Act, or a &#8220;qualified institutional buyer&#8221; as defined in Rule 144(a) of under the Securities Act. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(d) <u>Experience of Such Purchaser.</u> Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">16</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(e) <u>Access to Information.</u> Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(f) <u>Certain Transactions and Confidentiality.</u> Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material pricing terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&#8217;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(g) <u>Brokers.</u> Except as set forth in the Preliminary Prospectus or Prospectus, no agent, broker, investment banker, person or firm acting in a similar capacity on behalf of or under the authority of the Purchaser is or will be entitled to any broker&#8217;s or finder&#8217;s fee or any other commission or similar fee, directly or indirectly, for which the Company or any of its Affiliates after the Closing could have any liabilities in connection with this Agreement, any of the transactions contemplated by this Agreement, or on account of any action taken by the Purchaser in connection with the transactions contemplated by this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; TEXT-INDENT: 45px; text-align:justify;">(h) <u>Independent Advice.</u> Each Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&#8217;s right to rely on the Company&#8217;s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">17</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ARTICLE IV.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">OTHER AGREEMENTS OF THE PARTIES</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:0in"><strong>ARTICLE I. OTHER AGREEMENTS OF THE PARTIES</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:45px">4.1 <u>Legends</u>. The Shares, the Common Warrants and, if all or any portion of a Common Warrant is exercised at a time when there is an effective registration statement to cover the issuance or resale of the Warrant Shares or if the Common Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant to any such exercise, shall be issued free of all legends. If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available for the sale or resale of the Shares, the Common Warrants or the Warrant Shares, the Company shall promptly notify the holders of the Common Warrants in writing that such registration statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and available for the sale or resale of the Shares, the Common Warrants or the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any Purchaser to sell, any of the Warrant Shares in compliance with applicable federal and state securities laws). The Company shall use best efforts to keep a registration statement (including the Registration Statement) registering the issuance or resale of the Warrant Shares effective during the term of the Common Warrants.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.2 <u>Furnishing of Information</u>. Until the earlier of the time that no Purchaser owns Securities or the Common Warrants have expired, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.3 <u>Integration</u>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market in a manner that would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.4 <u>Securities Laws Disclosure; Publicity.</u> The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations in which case the Company shall, to the extent permitted by applicable law, provide the Purchasers with prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">18</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.5 <u>Shareholder Rights Plan.</u> No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &#8220;Acquiring Person&#8221; under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.6 <u>Non-Public Information.</u> Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public information to a Purchaser without such Purchaser&#8217;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.7 <u>Use of Proceeds.</u> The Company shall use the net proceeds from the sale of the Securities as set forth in the Prospectus Supplement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.8 <u>Indemnification of Purchasers.</u> Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#8220;Purchaser Party&#8221;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&#8217;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct), or (c) in connection with any registration statement of the Company providing for the resale by the Purchasers of the Warrant Shares issued and issuable upon exercise of the Common Warrants, the Company will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&#8217; fees) and expenses, as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in such registration statement, any prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding such Purchaser Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in connection therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and, the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable and documented out-of-pocket fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&#8217;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&#8217;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents as determined by a final, non-appealable judgment of a court of competent jurisdiction. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">19</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.9 <u>Reservation of Common Stock.</u> As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Common Warrants. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.10 <u>Listing of Common Stock.</u> The Company hereby agrees to use its reasonable best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&#8217;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.11 <u>[RESERVED] </u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.12 <u>Subsequent Equity Sales.</u> </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">(a) From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated by this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">20</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">(b) From the date hereof until 180 days after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction.&nbsp;&nbsp;&#8220;Variable Rate Transaction&#8221; means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit whereby the Company may issue securities at a future determined price regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled; provided, however, that&nbsp;the entry into and/or issuance of shares of Common Stock in an &#8220;at-the-market&#8221; facility shall not be deemed a Variable Rate Transaction. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">(c) Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.13 <u>Equal Treatment of Purchasers.</u> No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.14 <u>Certain Transactions and Confidentiality.</u> Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company&#8217;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules (other than as disclosed to its legal and other representatives). Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, after the issuance of the initial press release as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.15 <u>Exercise Procedures. </u>The form of Notice of Exercise included in the Common Warrants set forth the totality of the procedures required of the Purchasers in order to exercise the Common Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Common Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Common Warrants. The Company shall honor exercises of the Common Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">21</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4.16 <u>Lock-Up Agreements.</u> The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements (or any substantially similar lock-up agreements signed by transferees of the initial parties to the Lock-Up Agreements) except to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement (or any substantially similar lock-up agreements signed by transferees of the initial parties to the Lock-Up Agreements) in accordance with its terms. If any party to a Lock-Up Agreement (or any substantially similar lock-up agreements signed by transferees of the initial parties to the Lock-Up Agreements) breaches any provision of such agreement, the Company shall promptly use its best efforts to seek specific performance of the terms of such agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ARTICLE V.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">MISCELLANEOUS</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.1 <u>Termination.</u> This Agreement may be terminated by any Purchaser, as to such Purchaser&#8217;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the fifth (5<sup style="vertical-align:super">th</sup>) Trading Day following the date hereof; provided, however, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.2 <u>Fees and Expenses.</u> Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.3 <u>Entire Agreement.</u> The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.4 <u>Notices.</u> Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<sup style="vertical-align:super">nd</sup>) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.5 <u>Amendments; Waivers.</u> No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers who purchased at least 50.1% in interest of the Shares and Common Warrants based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">22</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.6 <u>Headings.</u> The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.7 <u>Successors and Assigns.</u> This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the &#8220;Purchasers.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.8 <u>No Third-Party Beneficiaries.</u> The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.9 <u>Governing Law.</u> All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.10 <u>Survival.</u> The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.11 <u>Execution.</u> This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &#8220;.pdf&#8221; format data file including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such &#8220;.pdf&#8221; signature page were an original thereof.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">23</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.12 <u>Severability</u>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.13 <u>Rescission and Withdrawal Right.</u> Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however, that in the case of a rescission of an exercise of a Common Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&#8217;s right to acquire such shares pursuant to such Purchaser&#8217;s Common Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>5.14 Replacement of Securities.</u> If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.15 <u>Remedies.</u> In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.16 <u>Payment Set Aside.</u> To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.17 <u>Independent Nature of Purchasers&#8217; Obligations and Rights.</u> The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through Sichenzia Ross Ference Carmel LLP. Sichenzia Ross Ference Carmel LLP does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">24</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.18 <u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.19 <u>Liquidated Damages.</u> The Company&#8217;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.20 <u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5.21 <u>Construction.</u> The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><strong>5.22 <u>WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>(Signature Pages Follow)</em></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">25</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:58%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>374Water Inc.</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><u>Address for Notice:</u></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">701 W. Main Street, Suite 410 </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Durham, NC 27701</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:3%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">By:</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:20%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:42%;"> <p style="margin:0px">E-Mail: [***]</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">Name:&nbsp;Christian Gannon</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">Title:&nbsp;President and Chief Executive Officer</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">With a copy to (which shall not constitute notice):</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Orrick, Herrington &amp; Sutcliffe LLP, with offices located at The Orrick Building, 405 Howard Street, San Francisco, CA 94105-2669.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Telephone: [***]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Attention: Justin &#8220;J.T.&#8221; Ho</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">E-Mail: [***]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">26</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">[PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name of Purchaser: ________________________________________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Signature of Authorized Signatory of Purchaser</em>: _________________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Name of Authorized Signatory: _______________________________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Title of Authorized Signatory: ________________________________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Email Address of Authorized Signatory: _________________________________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Address for Notice to Purchaser:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Address for Delivery of Common Warrants to Purchaser (if not same as address for notice):</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Subscription Amount: $_________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Shares: _________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Common Warrants: ___________&nbsp;&nbsp; Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">EIN Number: _______________________</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;&nbsp; Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing shall occur on the first (1<sup style="vertical-align:super">st</sup>) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">[SIGNATURE PAGES CONTINUE]</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">27</td></tr></table><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>scwo_ex102.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT
<TEXT>
<html><head><title>scwo_ex102.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>&nbsp;EXHIBIT 10.2</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT MARKED BY &#8220;[***]&#8221; HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE COMPANY TREATS AS PRIVATE OR CONFIDEN1TIAL.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>PLACEMENT AGENCY AGREEMENT</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">November 14, 2024</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">374Water Inc.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">701 W Main Street,&nbsp;Suite 410</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Durham,&nbsp;NC&nbsp;27701</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">374Water Inc</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Attention: Chris Gannon, President and Chief Executive Officer </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Dear Mr. Gannon:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 45px; text-align:justify;">This agreement (the &#8220;<strong>Agreement</strong>&#8221;) constitutes the agreement between D. Boral Capital LLC (the &#8220;<strong>Placement Agent</strong>&#8221; or &#8220;<strong>D. Boral</strong>&#8221;) and 374Water Inc., a corporation incorporated under the laws of Delaware (the &#8220;<strong>Company</strong>&#8221;), pursuant to which the Placement Agent shall serve as the exclusive placement agent for the Company, on a &#8220;reasonable best efforts&#8221; basis, in connection with the proposed placement (the &#8220;<strong>Placement</strong>&#8221;) of registered Common Stock (the &#8220;<strong>Shares</strong>&#8221;) of the Company, par value $0.0001&nbsp;&nbsp;per share (the &#8220;<strong>Common Stock&#8221;)</strong>, common stock purchase warrants to purchase Common Stock (the&nbsp;&nbsp;&#8220;<strong>Warrants</strong>&#8221;). The Shares, the Warrants, and the Common Stock underlying the Warrants are collectively referred to herein as the &#8220;<strong>Securities</strong>&#8221;). The terms of the Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a &#8220;<strong>Purchaser</strong>&#8221; and collectively, the &#8220;<strong>Purchasers</strong>&#8221;) and nothing herein constitutes that the Placement Agent would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement.&nbsp;&nbsp;This Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the Placement, including but not limited to the Purchase Agreement (as defined below), and the form of the Warrants shall be collectively referred to herein as the &#8220;<strong>Transaction</strong> <strong>Documents</strong>.&#8221;&nbsp;&nbsp;The date of the closing of the Placement shall be referred to herein as the &#8220;<strong>Closing Date</strong>.&#8221; The Company expressly acknowledges and agrees that the Placement Agent&#8217;s obligations hereunder are on a reasonable best efforts basis only and that the execution of this Agreement does not constitute a commitment by the Placement Agent to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of the Placement Agent with respect to securing any other financing on behalf of the Company.&nbsp;&nbsp;With the prior written consent of the Company, the Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Placement.&nbsp;&nbsp;The sale of the Securities to any Purchaser will be evidenced by a securities purchase agreement (the &#8220;<strong>Purchase</strong> <strong>Agreement</strong>&#8221;) between the Company and such Purchaser in a form reasonably acceptable to the Company and the Placement Agent.&nbsp;&nbsp;Capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Purchase Agreement.&nbsp;&nbsp;Prior to the signing of any Purchase Agreement, officers of the Company will be available to answer inquiries from prospective Purchasers.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 1. REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</u>.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">A. <u>Representations of the Company</u>. Each of the representations and warranties (together with any related disclosure schedules thereto) and covenants made by the Company to the Purchasers in the Purchase Agreement in connection with the Placement is hereby incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of the date of this Agreement and as of the Closing Date, hereby made to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents and warrants that:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">1. The Company has prepared and filed with the U.S. Securities and Exchange Commission (the &#8220;<strong>Commission</strong>&#8221;) a registration statement on Form S-3, as amended (Registration No. 333-<strong> </strong>268942), and amendments thereto, and related preliminary prospectuses, for the registration under the Securities Act of 1933, as amended (the &#8220;<strong>Securities Act</strong>&#8221;), of the Securities which registration statement, as so amended (including post-effective amendments, if any) became effective on December 30, 2022. At the time of such filing, the Company met the requirements of Form S-3 under the Securities Act. Such registration statement meets the requirements set forth in Rule 415(a)(1)(x) under the Securities Act and complies with said Rule. The Company will file with the Commission pursuant to Rule 424(b) under the Securities Act, and the rules and regulations (the &#8220;<strong>Rules and Regulations</strong>&#8221;) of the Commission promulgated thereunder, a supplement to the form of prospectus included in such registration statement relating to the placement of the Securities and the plan of distribution thereof and has advised the Placement Agent of all further information (financial and other) with respect to the Company required to be set forth therein. Such registration statement, including the exhibits thereto, as amended at the date of this Agreement, is hereinafter called the &#8220;<strong>Registration Statement</strong>&#8221;; such prospectus in the form in which it appears in the Registration Statement is hereinafter called the &#8220;<strong>Base Prospectus</strong>&#8221;; and the supplemented form of prospectus, in the form in which it will be filed with the Commission pursuant to Rule 424(b) (including the Base Prospectus as so supplemented) is hereinafter called the &#8220;<strong>Prospectus Supplement</strong>.&#8221; Any reference in this Agreement to the Registration Statement, the Base Prospectus or the Prospectus Supplement shall be deemed to refer to and include the documents incorporated by reference therein (the &#8220;<strong>Incorporated Documents</strong>&#8221;) which were filed under the Exchange Act on or before the date of this Agreement, or the issue date of the Base Prospectus or the Prospectus Supplement, as the case may be; and any reference in this Agreement to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement, the Base Prospectus or the Prospectus Supplement shall be deemed to refer to and include the filing of any document under the Exchange Act after the date of this Agreement, or the issue date of the Base Prospectus or the Prospectus Supplement, as the case may be, deemed to be incorporated therein by reference. All references in this Agreement to financial statements and schedules and other information which is &#8220;contained,&#8221; &#8220;included,&#8221; &#8220;described,&#8221; &#8220;referenced,&#8221; &#8220;set forth&#8221; or &#8220;stated&#8221; in the Registration Statement, the Base Prospectus or the Prospectus Supplement (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information which is or is deemed to be incorporated by reference in the Registration Statement, the Base Prospectus or the Prospectus Supplement, as the case may be. No stop order suspending the effectiveness of the Registration Statement or the use of the Base Prospectus or the Prospectus Supplement has been issued, and no proceeding for any such purpose is pending or has been initiated or, to the Company&#8217;s knowledge, is threatened by the Commission. For purposes of this Agreement, &#8220;<strong>free writing prospectus</strong>&#8221; has the meaning set forth in Rule 405 under the Securities Act and the &#8220;<strong>Time of Sale Prospectus</strong>&#8221; means the preliminary prospectus, if any, together with the free writing prospectuses, if any, used in connection with the Placement, including any documents incorporated by reference therein.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">2. The Registration Statement (and any further documents to be filed with the Commission) contains all material exhibits and schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all material respects with the Securities Act and the Exchange Act and the applicable Rules and Regulations and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Base Prospectus, the Time of Sale Prospectus and the Prospectus Supplement, each as of its respective date, comply in all material respects with the Securities Act and the Exchange Act and the applicable Rules and Regulations. Each of the Base Prospectus, the Time of Sale Prospectus and the Prospectus Supplement, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Incorporated Documents, when they were filed with the Commission, conformed in all material respects to the requirements of the Exchange Act and the applicable Rules and Regulations, and none of such documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein (with respect to Incorporated Documents incorporated by reference in the Base Prospectus or Prospectus Supplement), in the light of the circumstances under which they were made not misleading; and any further documents so filed and incorporated by reference in the Base Prospectus, the Time of Sale Prospectus or Prospectus Supplement, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and the applicable Rules and Regulations, as applicable, and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is required to be filed with the Commission. There are no documents required to be filed with the Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite time period. There are no contracts or other documents required to be described in the Base Prospectus, the Time of Sale Prospectus or Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, which (x) have not been described or filed as required or (y) will not be filed within the requisite time period.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">3. The Company is eligible to use free writing prospectuses in connection with the Placement pursuant to Rules 164 and 433 under the Securities Act. Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder. Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or behalf of or used by the Company complies or will comply in all material respects with the requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder. The Company will not, without the prior consent of the Placement Agent, which consent shall not be unreasonably withheld, prepare, use or refer to, any free writing prospectus.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 135px; text-align:justify;">4. There are no affiliations with any FINRA member firm among the Company&#8217;s officers, directors or, to the knowledge of the Company, any ten percent (10.0%) or greater shareholder of the Company, except as set forth in the Registration Statement and the other documents the Company has filed or furnished with the Commission.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">B. <u>Covenants of the Company</u>. The Company has delivered, or will as promptly as practicable deliver, to the Placement Agent materially complete conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof, and conformed copies of the Registration Statement (without exhibits), the Base Prospectus, the Time of Sale Prospectus and the Prospectus Supplement, as amended or supplemented, in such quantities and at such places as the Placement Agent reasonably requests. Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to the Closing Date, any offering material in connection with the offering and sale of the Securities pursuant to the Placement other than the Base Prospectus, the Time of Sale Prospectus, the Prospectus Supplement, the Registration Statement, copies of the documents incorporated by reference therein and any other materials permitted by the Securities Act.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 2. REPRESENTATIONS OF THE PLACEMENT AGENT</u>. The Placement Agent represents and warrants that it (i) is a member in good standing of FINRA, (ii) is registered as a broker/dealer under the Exchange Act, (iii) is licensed as a broker/dealer under the laws of the states applicable to the offers and sales of the Securities by such Placement Agent, (iv) is and will be a body corporate validly existing under the laws of its place of incorporation, and (v) has full power and authority to enter into and perform its obligations under this Agreement. The Placement Agent will immediately notify the Company in writing of any change in its status as such. The Placement Agent covenants that it will use its reasonable best efforts to conduct the Placement hereunder in compliance with the provisions of this Agreement and the requirements of applicable law.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 3. COMPENSATION</u>. In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent or their respective designees their pro rata portion (based on the Securities placed) of the following compensation with respect to the Securities which they are placing:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">A. A cash fee equal to (i) an aggregate of five percent (5%) of the aggregate gross proceeds raised in the Placement from the sale of securities by the Company to Purchasers introduced to the Company by the Placement Agent; and (ii) an aggregate of two and a half percent (2.5%) of the aggregate gross proceeds raised in the Placement from the sale of securities by the Company to Purchasers introduced by the Company; provided however, that the gross proceeds raised in the Placement from the sale of securities by the Company to the Purchasers introduced by D. Boral are equal to or greater than $5,000,000 (the &#8220;<strong>Cash Fee</strong>&#8221;). The Cash Fee shall be limited to the proceeds from the Placement and paid at the closing of the Placement (the &#8220;<strong>Closing</strong>&#8221;).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">B. Subject to compliance with FINRA Rule 5110(f)(2)(D), the Company also agrees, (i) in the event that the Company consummates the Placement, to pay, or reimburse if paid by the Placement Agent, all reasonable and documented out-of-pocket costs and expenses incident to the performance of the obligations of the Placement Agent under this Agreement (including, without limitation, the fees and expenses of the Placement Agent&#8217;s outside attorneys), provided that, except as otherwise provided in Addendum A, such costs and expenses shall not exceed $75,000 without the Company&#8217;s prior written approval (such approval not to be unreasonably withheld, conditioned or delayed) and (ii) in the event that the Company executes a term sheet with a Purchaser but at the Company&#8217;s election the Placement is not consummated, the Company shall still reimburse the Placement Agent for its incurred accountable reasonable and documented out-of-pocket expenses subject to a cap of $25,000. The Company will pay or reimburse Placement Agent directly upon the Closing of the Placement from the gross proceeds raised in the Placement for all amounts owed under clause (i) of the preceding sentence. For the avoidance of doubt, in the event that the Company does not consummate the Placement at the election of the Placement Agent or the Purchasers, the Company shall have no obligation to reimburse the Placement Agent for any costs and expenses.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">C. The Placement Agent reserves the right to reduce any item of its compensation or adjust the terms thereof as specified herein in the event that a determination shall be made by FINRA to the effect that such Placement Agent&#8217;s aggregate compensation is in excess of FINRA rules or that the terms thereof require adjustment.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 4. INDEMNIFICATION</u>. The Company agrees to the indemnification and other agreements set forth in the Indemnification Provisions (the &#8220;<strong>Indemnification</strong>&#8221;) attached hereto as <u>Addendum A</u>, the provisions of which are incorporated herein by reference and shall survive the termination or expiration of this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 5. ENGAGEMENT TERM</u>. The Placement Agent&#8217;s engagement hereunder shall be until the earlier of (i) the final closing date of the Placement and (ii) the date when either party to this Agreement terminates the engagement according to the terms as set forth in the next sentence (such date, the &#8220;<strong>Termination Date</strong>&#8221;). The Agreement may be terminated at any time by either party upon 10 days written notice to the other party. Notwithstanding anything to the contrary contained herein, the provisions concerning confidentiality, indemnification, contribution and the Company&#8217;s obligations to pay fees and reimburse expenses contained herein and the Company&#8217;s obligations contained in the Indemnification Provisions will survive any expiration or termination of this Agreement for twelve (12) months, irrespective of whether a closing occurs. All such fees and reimbursements due shall be paid to the Placement Agent on or before the Termination Date (in the event such fees and reimbursements are earned or owed as of the Termination Date) or upon the closing of the Placement or any applicable portion thereof (in the event such fees and reimbursements are due as of the Termination Date). The Placement Agent agrees not to use any confidential information concerning the Company provided to them by the Company for any purposes other than those contemplated under this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 6. PLACEMENT AGENT INFORMATION</u>. The Company agrees that any information or advice rendered by the Placement Agent in connection with this engagement is for the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required by law, the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&#8217;s prior written consent.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 7.</u>LOCK-UP AGREEMENT. The Company&#8217;s directors and officers shall enter into customary &#8220;lock-up&#8221; agreements in favor of the Placement Agent pursuant to which such persons and entities shall agree, for a period of three (3) months after the final closing of the Placement, that they shall not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company, subject to customary exceptions.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 8. NO FIDUCIARY RELATIONSHIP</u>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person or entity not a party hereto, except those entitled hereto by virtue of the Indemnification Provisions hereof. The Company acknowledges and agrees that the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of such Placement Agent hereunder, all of which are hereby expressly waived.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 9. CLOSING</u>. The obligations of the Placement Agent, and the closing of the sale of the Securities hereunder are subject to the accuracy, when made and on the Closing Date, of the representations and warranties on the part of the Company and its subsidiaries contained herein and in the Purchase Agreement, to the accuracy of the statements of the Company and its subsidiaries made in any certificates pursuant to the provisions hereof, to the performance by the Company and its subsidiaries of their obligations hereunder, and to each of the following additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agent to the Company:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">A. No stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall have been initiated or threatened by the Commission, and any request for additional information on the part of the Commission (to be included in the Registration Statement, the Base Prospectus, the Prospectus Supplement or otherwise) shall have been complied with to the reasonable satisfaction of the Placement Agent. Any filings required to be made by the Company in connection with the Placement shall have been timely filed with the Commission.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">B. The Placement Agent shall not have discovered and disclosed to the Company on or prior to the Closing Date that the Registration Statement, the Base Prospectus, the Prospectus Supplement or any amendment or supplement thereto contains an untrue statement of a fact which, in the reasonable opinion of counsel for the Placement Agent, is material or omits to state any fact which, in the reasonable opinion of such counsel, is material and is required to be stated therein or is necessary to make the statements therein not misleading.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">C. All corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement, the Shares, the Registration Statement, the Base Prospectus and the Prospectus Supplement and all other legal matters relating to this Agreement and the transactions contemplated hereby shall be reasonably satisfactory in all material respects to counsel for the Placement Agent, and the Company shall have furnished to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">D. The Placement Agent shall have received from outside counsel to the Company such counsel&#8217;s written opinions, including a negative assurance letter, addressed to the Placement Agent and the Purchasers and dated as of the Closing Date, in form and substance reasonably satisfactory to the Placement Agent.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">E. On the Closing Date, the Placement Agent shall have received a certificate from the Chief Financial Officer of the Company as of such date, addressed to each of the Placement Agent and in form and substance satisfactory in all respects to the Placement Agent and Placement Agent&#8217;s counsel.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">F. On the Closing Date, Placement Agent shall have received a certificate of an authorized officer of the Company, dated, as applicable, as of the date of such Closing, to the effect that, as of the date of this Agreement and as of the applicable date, the representations and warranties of the Company contained herein and in the Purchase Agreement were and are accurate in all material respects, except for such changes as are contemplated by this Agreement and except as to representations and warranties that were expressly limited to a state of facts existing at a time prior to the applicable Closing Date, and that, as of the applicable date, the obligations to be performed by the Company hereunder on or prior thereto have been fully performed in all material respects.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">G. On the Closing Date, Placement Agent shall have received a certificate of the Secretary of the Company, dated as of the date of such Closing, certifying to the organizational documents, good standing in the jurisdiction of incorporation of the Company and board resolutions relating to the Placement of the Securities from the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">H. Neither the Company nor any of its subsidiaries (i) shall have sustained since the date of the latest audited financial statements included or incorporated by reference in the Registration Statement, the Base Prospectus and the Prospectus Supplement, any loss or interference with its business from fire, explosion, flood, terrorist act or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth in or contemplated by the Registration Statement, the Base Prospectus and the Prospectus Supplement, (ii) since such date there shall not have been any change in the capital stock or long-term debt of the Company or any of its subsidiaries or any change, or any development involving a prospective change, in or affecting the business, general affairs, management, financial position, shareholders&#8217; equity, results of operations or prospects of the Company and its subsidiaries, otherwise than as set forth in or contemplated by the Registration Statement, the Base Prospectus and the Prospectus Supplement, and (iii) since such date there shall not have been any new or renewed inquiries by the Commission, FINRA or any other regulatory body regarding the Company, the effect of which, in any such case described in clause (i), (ii) or (iii), is, in the judgment of the Placement Agent, so material and adverse as to make it impracticable or inadvisable to proceed with the sale or delivery of the Securities on the terms and in the manner contemplated by the Base Prospectus, Time of Sale Prospectus and Prospectus Supplement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">I. The Common Stock is registered under the Exchange Act and, as of the Closing Date, the Shares and the Common Stock underlying the Warrants shall be listed and admitted and authorized for trading on the Nasdaq Capital Market (the &#8220;<strong>Trading Market</strong>&#8221;) or other applicable U.S. national exchange, or an application for such listing shall have been submitted to the Trading Market, and satisfactory evidence of such action shall have been provided to the Placement Agent. The Company shall have taken no action designed to, or likely to have the effect of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market or other applicable U.S. national exchange, nor, except as disclosed in the Base Prospectus, Time of Sale Prospectus and Prospectus Supplement, has the Company received any information suggesting that the Commission or the Trading Market or other U.S. applicable national exchange is contemplating terminating such registration or listing.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">J. No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance or sale of the Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">K. The Company shall have prepared and filed with the Commission a Form 8-K with respect to the Placement, including as an exhibit thereto this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">L. The Company shall have entered into a Purchase Agreement with each of the Purchasers and such agreements shall be in full force and effect and shall contain representations, warranties and covenants of the Company as agreed between the Company and the Purchasers.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">M. FINRA shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the Company shall, if requested by the Placement Agent, make or authorize Placement Agent&#8217;s counsel to make on the Company&#8217;s behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Placement and pay all filing fees required in connection therewith.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">N. On the date hereof, Placement Agent shall have received signed Lock-Up Agreements, addressed to the Placement Agent by each of the Company&#8217;s directors and officers.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">O. Prior to the Closing Date, the Company shall have furnished to the Placement Agent such further information, certificates and documents as the Placement Agent may reasonably request.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">If any of the conditions specified in this Section 9 shall not have been fulfilled when and as required by this Agreement, or if any of the certificates, opinions, written statements or letters furnished to the Placement Agent or to Placement Agent&#8217;s counsel pursuant to this Section 9 shall not be reasonably satisfactory in form and substance to the Placement Agent and to Placement Agent&#8217;s counsel, all obligations of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the consummation of the Closing. Notice of such cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 10.</u> [***]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 11. GOVERNING LAW; AGENT FOR SERVICE OF PROCESS, ETC</u>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to agreements made and to be performed entirely in such State, without regard to the conflicts of laws principles thereof. This Agreement may not be assigned by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement may be brought into the courts of the State of New York or into the federal court located in New York, New York and, by execution and delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and consents, to the extent permitted by applicable law, to process being served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. The Company agrees that a final judgment in any such action, proceeding or counterclaim brought in any such court shall be conclusive and binding upon the Company and may be enforced in any other courts to the jurisdiction of which the Company is or may be subject, by suit upon such judgment. If either party shall commence an action or proceeding to enforce any provisions of a Transaction Document, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney&#8217;s fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. In addition to and without limiting the foregoing, the Company has confirms that it has appointed Christian Gannon, as its authorized agent (the &#8220;<strong>Authorized Agent</strong>&#8221;) upon whom process may be served in any suit, action or proceeding arising out of or based upon the this Agreement or the Transaction Documents or the transactions contemplated herein which may be instituted in any New York federal or state court, by the Placement Agent, the directors, officers, partners, members, managers, employees and agents of the Placement Agent, and expressly accept the non-exclusive jurisdiction of any such court in respect of any such suit, action or proceeding. The Company hereby represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, and the Company agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. The Company hereby authorizes and directs the Authorized Agent to accept such service. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Company. If the Authorized Agent shall cease to act as agent for service of process, the Company shall appoint, without unreasonable delay, another such agent in the United States, and notify you of such appointment. Notwithstanding the foregoing, any action arising out of or based upon this Agreement may be instituted by the Placement Agent, the directors, officers, partners, members, managers, employees and agents of the Placement Agent, in any court of competent jurisdiction in the State of New York. This paragraph shall survive any termination of this Agreement, in whole or in part.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 12. ENTIRE AGREEMENT/MISCELLANEOUS</u>. This Agreement (including the attached Indemnification Provisions) embodies the entire agreement and understanding between the parties hereto, and supersedes all prior agreements and understandings, relating to the subject matter hereof. If any provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except by an instrument in writing signed by both Placement Agent and the Company. The representations, warranties, agreements and covenants contained herein shall survive the closing of the Placement and delivery of the Securities. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 13. CONFIDENTIALITY</u>. The Placement Agent (i) will keep the Confidential Information (as such term is defined below) confidential and will not (except as required by applicable law or stock exchange requirement, regulation or legal process (&#8220;<strong>Legal Requirement</strong>&#8221;), without the Company&#8217;s prior written consent, disclose to any person any Confidential Information, and (ii) will not use any Confidential Information other than in connection with the Placement. The Placement Agent further agrees, severally and not jointly, to disclose the Confidential Information only to its Representatives (as such term is defined below) who need to know the Confidential Information for the purpose of the Placement, and who are informed by the Placement Agent of the confidential nature of the Confidential Information. The term &#8220;<strong>Confidential Information</strong>&#8221; shall mean, all confidential, proprietary and non-public information (whether written, oral or electronic communications) furnished by the Company to a Placement Agent or its Representatives in connection with such Placement Agent&#8217;s evaluation of the Placement. The term &#8220;<strong>Confidential Information</strong>&#8221; will not, however, include information which (i) is or becomes publicly available other than as a result of a disclosure by a Placement Agent or its Representatives in violation of this Agreement, (ii) is or becomes available to a Placement Agent or any of its Representatives on a non-confidential basis from a third-party who, to the Placement Agent&#8217;s and its Representatives&#8217; knowledge, as applicable, is not bound by obligations of confidentiality to the Company with respect to such information, (iii) is known to a Placement Agent or any of its Representatives prior to disclosure by the Company or any of its Representatives from a source not bound by obligations of confidentiality to the Company with respect to such information, or (iv) is or has been independently developed by a Placement Agent and/or the Representatives without use of any Confidential Information furnished to it by the Company. The term &#8220;Representatives&#8221; shall mean the Placement Agent&#8217;s directors, board committees, officers, employees, financial advisors, attorneys and accountants. This provision shall be in full force until the earlier of (a) the date that the Confidential Information ceases to be confidential and (b) two years from the date hereof. Notwithstanding any of the foregoing, in the event that the Placement Agent or any of their respective Representatives are required by Legal Requirement to disclose any of the Confidential Information, such Placement Agent and their respective Representatives will notify the Company in writing, as promptly as practicable, prior to disclosure of such information, and furnish only that portion of the Confidential Information which such Placement Agent or their respective Representative, as applicable, is required to disclose by Legal Requirement as advised by counsel, and will use reasonable efforts to obtain reliable assurance that confidential treatment will be accorded the Confidential Information so disclosed.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 14. NOTICES</u>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent to the email address specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b) the next business day after the date of transmission, if such notice or communication is sent to the email address on the signature pages attached hereto on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third business day following the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages hereto.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><u>SECTION 15. PRESS ANNOUNCEMENTS</u>. The Company agrees that the Placement Agent shall, from and after any public announcement of the Closing, have the right to reference the Placement and the Placement Agent&#8217;s role in connection therewith in the Placement Agent&#8217;s marketing materials and on its website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>[The remainder of this page has been intentionally left blank.]</em></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Please confirm that the foregoing correctly sets forth our agreement by signing and returning to D. Boral the enclosed copy of this Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td>&nbsp;</td> <td colspan="2"> <p style="margin:0px">Very truly yours,</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"><strong>D. Boral Capital LLC</strong></p></td> <td></td></tr> <tr style="height:15px"> <td style="width:50%;">&nbsp;</td> <td style="width:5%;">&nbsp;</td> <td style="width:35%;">&nbsp;</td> <td style="width:10%;">&nbsp;</td></tr> <tr style="height:15px"> <td></td> <td>By:</td> <td style="BORDER-BOTTOM: black 1px solid;">/s/ Philip Wiederlight</td> <td></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">Name:</p></td> <td>Philip Wiederlight</td> <td>&nbsp;</td></tr> <tr style="height:15px"> <td>&nbsp;</td> <td>Title:</td> <td>Chief Operating Officer</td> <td>&nbsp;</td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td colspan="2"> <p style="margin:0px">Address for notice:</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">590 Madison Avenue, 39th Floor</p> <p style="margin:0px">New York, NY 10022</p> <p style="margin:0px">Attention: Philip Wiederlight, Chief Operating Officer</p> <p style="margin:0px">Email: [***]</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accepted and Agreed to as of the date first written above:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>374WATER INC.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:3%;"> <p style="margin:0px">By:</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:35%;"> <p style="margin:0px">/s/ Christian Gannon</p></td> <td style="width:12%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:50%;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">Name:</p></td> <td> <p style="margin:0px">Christian Gannon</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">Title:</p></td> <td> <p style="margin:0px">President and Chief Executive Officer</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Address for notice:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">374Water Inc.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">701 W Main Street, Suite 410</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Durham, NC 27701</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Attention: Christian Gannon, President and Chief Executive Officer</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Email: [***]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>ADDENDUM A</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><u>INDEMNIFICATION PROVISIONS</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">In connection with the engagement of D. Boral Capital LLC (the &#8220;Placement Agent&#8221;) by 374Water Inc. (the &#8220;Company&#8221;) pursuant to a placement agency agreement dated as of the date hereof, between the Company and the Placement Agent, as it may be amended from time to time in writing (the &#8220;Agreement&#8221;), the Company hereby agrees as follows:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">1. To the extent permitted by law, the Company will indemnify the Placement Agent and its affiliates, directors, officers, employees and controlling persons (within the meaning of Section 15 of the Securities Act of 1933, as amended, or Section 20 of the Securities Exchange Act of 1934) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including the reasonable fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to the Agreement, except, with regard to the Placement Agent, to the extent that any losses, claims, damages, expenses or liabilities (or actions in respect thereof) are found in a final judgment (not subject to appeal) by a court of law to have resulted primarily and directly from any indemnitee&#8217;s bad faith, willful misconduct, fraud or gross negligence.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">2. Promptly after receipt by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to which the Placement Agent is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such claim or of the commencement of such action or proceeding, and the Company will assume the defense of such action or proceeding and will employ counsel reasonably satisfactory to the Placement Agent and will pay the reasonable fees and expenses of such counsel. Notwithstanding the preceding sentence, the Placement Agent will be entitled to employ counsel separate from counsel for the Company and from any other party in such action if counsel for the Placement Agent reasonably determines that it would be inappropriate under the applicable rules of professional responsibility for the same counsel to represent both the Company and the Placement Agent. In such event, the reasonable fees and disbursements of no more than one such separate counsel will be paid by the Company. The Company will have the exclusive right to settle the claim or proceeding provided that the Company will not settle any such claim, action or proceeding without the prior written consent of the Placement Agent, which will not be unreasonably withheld. The Placement Agent and all other indemnitees shall not settle any claim, action or proceeding without the prior written consent of the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">3. The Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement of any action or proceeding relating to a transaction contemplated by the Agreement.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">4. If for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless, then the Company shall contribute to the amount paid or payable by the Placement Agent, as the case may be, as a result of such losses, claims, damages or liabilities in such proportion as is appropriate to reflect not only the relative benefits received by the Company on the one hand, and the Placement Agent on the other, but also the relative fault of the Company on the one hand and the Placement Agent on the other that resulted in such losses, claims, damages or liabilities, as well as any relevant equitable considerations. The amounts paid or payable by a party in respect of losses, claims, damages and liabilities referred to above shall be deemed to include any legal or other fees and expenses incurred in defending any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof, the Placement Agent&#8217;s share of the liability hereunder shall not be in excess of the amount of fees actually received, or to be received, by the Placement Agent under the Agreement (excluding any amounts received as reimbursement of expenses incurred by the Placement Agent).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">5. These Indemnification Provisions shall remain in full force and effect whether or not the transaction contemplated by the Agreement is completed and shall survive the termination of the Agreement, and shall be in addition to any liability that the Company might otherwise have to any indemnified party under the Agreement or otherwise.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>scwo_ex103.htm
<DESCRIPTION>FORM OF LOCK-UP AGREEMENT
<TEXT>
<html><head><title>scwo_ex103.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: left; FONT: 10pt times new roman; MARGIN: 0px 7%"><p style="MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.3</strong></p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 3pt; text-align:center;"><strong>Form<strong> </strong>of<strong> </strong>Lock-Up<strong> </strong><strong>Agreement</strong></strong></p> <p style="MARGIN: 0px 0px 0px 5pt; TEXT-INDENT: 175pt; text-align:right;">November 14, 2024 </p> <p style="margin:0px 0px 0px 5pt">D. Boral Capital LLC</p> <p style="margin:0px 0px 0px 5pt">590 Madison Avenue, 39th Floor</p> <p style="MARGIN: 0px 0px 0px 5pt; text-align:justify;">New York, NY 10022 Ladies and Gentlemen:</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 5pt; TEXT-INDENT: 35.95pt; text-align:justify;">The undersigned, a holder of securities of 374Water Inc., a corporation incorporated under the laws of Delaware (the &#8220;<strong>Company</strong>&#8221;), understands that you are the placement agent (the &#8220;<strong>Placement Agent</strong>&#8221;) named in the placement agency agreement (the &#8220;<strong>Placement Agency Agreement</strong>&#8221;) entered into between the Placement Agent and the Company, providing for the placement (the &#8220;<strong>Placement</strong>&#8221;) of securities of the Company (the &#8220;<strong>Securities</strong>&#8221;) pursuant to a registration statement and related prospectuses and supplements thereto filed or to be filed with the U.S. Securities and Exchange Commission (the &#8220;<strong>SEC</strong>&#8221;).</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 5pt; TEXT-INDENT: 35.95pt; text-align:justify;">In consideration of the Placement Agent&#8217;s agreement to proceed with the Placement of the Securities, and for other good and valuable consideration, receipt of which is hereby acknowledged, the undersigned hereby agrees, for the benefit of the Company and the Placement Agent that, without the prior written consent of the Placement Agent, the undersigned will not, during the period specified in the following paragraph (the &#8220;<strong>Lock-Up Period</strong>&#8221;), directly or indirectly, unless otherwise provided herein, (a) offer, sell, agree to offer or sell, solicit offers to purchase, convert, exercise, exchange, grant any call option or purchase any put option with respect to, pledge, encumber, assign, borrow or otherwise dispose of or transfer (each a &#8220;<strong>Transfer</strong>&#8221;) any Relevant Security (as defined below) or otherwise publicly disclose the intention to do so, or (b) establish or increase any &#8220;put equivalent position&#8221; or liquidate or decrease any &#8220;call equivalent position&#8221; (in each case within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the &#8220;<strong>Exchange Act</strong>&#8221;) and the rules and regulations thereunder) with respect to any Relevant Security or otherwise enter into any swap, derivative or other transaction or arrangement that Transfers to another, in whole or in part, any economic consequence of ownership of a Relevant Security, whether or not such transaction is to be settled by the delivery of Relevant Securities, other securities, cash or other consideration, or otherwise publicly disclose the intention to do so. As used herein, the term &#8220;<strong>Relevant Security</strong>&#8221; means any common stock, par value $0.001 per share, of the Company (&#8220;<strong>Share</strong>&#8221;), warrant to purchase Shares or any other security of the Company or any other entity that is convertible into, or exercisable or exchangeable for, Shares or any other equity security of the Company, in each case owned beneficially or otherwise by the undersigned on the date set forth on the front cover of the final prospectus supplement used in connection with the Placement of the Securities (the &#8220;<strong>Effective Date</strong>&#8221;) or acquired by the undersigned during the Lock-Up Period, including, for the avoidance of doubt, any Relevant Security acquired by the Undersigned in the Placement.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 5pt; TEXT-INDENT: 35.95pt; text-align:justify;">The Lock-Up Period will commence on the date of this Lock-up Agreement and continue and include the date that is three (3) months after the closing of the Placement.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 5pt; TEXT-INDENT: 35.95pt; text-align:justify;">In addition, the undersigned further agrees that, without the prior written consent of the Placement Agent, during the Lock-Up Period the undersigned will not: (i) file or participate in the filing with the SEC of any registration statement or circulate or participate in the circulation of any preliminary or final prospectus or other disclosure document, in each case with respect to any proposed offering or sale of a Relevant Security except as required by the terms of the Placement Agency Agreement, the Securities Purchase Agreement and the Securities subject to the Placement, or (ii) exercise any rights the undersigned may have to require registration with the SEC of any proposed offering or sale of a Relevant Security.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; TEXT-INDENT: 40.5pt; text-align:justify;">In furtherance of the undersigned&#8217;s obligations hereunder, the undersigned hereby authorizes the Company during the Lock-Up Period to cause any transfer agent for the Relevant Securities to decline to transfer, and to note stop transfer restrictions on the stock register and other records relating to, Relevant Securities for which the undersigned is the record owner and the transfer of which would be a violation of this Lock-Up Agreement and, in the case of Relevant Securities for which the undersigned is the beneficial but not the record owner, agrees that during the Lock-Up Period it will cause the record owner to cause the relevant transfer agent to decline to transfer, and to note stop transfer restrictions on the stock register and other records relating to, such Relevant Securities to the extent such transfer would be a violation of this Lock-Up Agreement. </p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="text-align:center;margin:0px">1</p></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">Notwithstanding the foregoing, the undersigned may transfer the undersigned&#8217;s Relevant Securities:</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:3%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:3%;vertical-align:top;"> <p style="margin:0px"><em>(i)</em></p></td> <td style="vertical-align:top;"> <p style="margin:0px"><em>as a bona fide gift or gifts,</em></p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px">(ii)</p></td> <td style="vertical-align:top;"> <p style="margin:0px">to any trust for the direct or indirect benefit of the undersigned or a member of members of the immediate family of the undersigned,</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px">(iii)</p></td> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px">if the undersigned is a corporation, partnership, limited liability company, trust or other business entity (1) to another corporation, partnership, limited liability company, trust or other business entity that is a direct or indirect affiliate (as defined in Rule 405 under the Securities Act of 1933, as amended) of the undersigned, (2) to limited partners, limited liability company members or stockholders of the undersigned, or (3) in connection with a sale, merger or transfer of all or substantially all of the assets of the undersigned or any other change of control of the undersigned, not undertaken for the purpose of avoiding the restrictions imposed by this Lock-Up Agreement,</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px">(iv)</p></td> <td style="vertical-align:top;"> <p style="margin:0px">if the undersigned is a trust, to the beneficiary of such trust,</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px">(v)</p></td> <td style="vertical-align:top;"> <p style="margin:0px">by testate or intestate succession,</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px">(vi)</p></td> <td style="vertical-align:top;"> <p style="margin:0px">to a charity or educational institution,</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px">(vii)</p></td> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px">upon a vesting event of the Company&#8217;s securities or upon the exercise of options to purchase the Company&#8217;s securities, in each case on a &#8220;cashless&#8221; or &#8220;net exercise&#8221; basis or to cover tax obligations of the undersigned in connection with the receipt by the undersigned from the Company of Shares upon the vesting of restricted stock awards or stock units or upon the exercise of options to purchase the Company&#8217;s Shares issued under an equity incentive plan of the Company or an employment arrangement or the transfer of Shares or any securities convertible into Shares to the Company, but only to the extent such right expires during the Lock-up Period, and</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px">(viii)</p></td> <td style="vertical-align:top;"> <p style="margin:0px">by operation of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;"><em>provided, </em>that (A) such transfer shall not involve a disposition for value, (B) the transferee agrees in writing with the Placement Agent and the Company to be bound by the terms of this Lock-Up Agreement, and (C) such transfer would not require any filing under Section 16(a) of the Exchange Act and no such filing is voluntarily made. Moreover, the undersigned shall be permitted to establish a trading plan pursuant to Rule 10b5-1 under the Exchange Act for the transfer of Relevant Securities, provided that (i) such plan does not provide for the transfer of Relevant Securities during the Lock-Up Period and (ii) to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on behalf of the undersigned or the Company regarding the establishment of such plan, such public announcement or filing shall include a statement to the effect that no transfer of Relevant Securities may be made under such plan during the Lock-Up Period.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 5pt; TEXT-INDENT: 35.95pt; text-align:justify;">For purposes of this Lock-Up Agreement, &#8220;immediate family&#8221; shall mean any relationship by blood, marriage or adoption, not more remote than first cousin.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 5pt; TEXT-INDENT: 35.95pt; text-align:justify;">The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement and that this Lock-Up Agreement has been duly authorized (if the undersigned is not a natural person) and constitutes the legal, valid and binding obligation of the undersigned, enforceable in accordance with its terms. Upon request, the undersigned will execute any additional documents necessary in connection with the enforcement hereof. Any obligations of the undersigned shall be binding upon the successors and assigns of the undersigned from the date of this Lock-Up Agreement.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 5pt; TEXT-INDENT: 35.95pt; text-align:justify;">The undersigned understands that, if the Placement Agency Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Securities to be sold thereunder, the undersigned shall be released from all obligations under this Lock-Up Agreement.</p> <p style="MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 5pt; TEXT-INDENT: 35.95pt; text-align:justify;">The undersigned, whether or not participating in the Placement, understands that the Placement Agent is proceeding with the Placement in reliance upon this Lock-Up Agreement.</p> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 3pt; text-align:center;">[<em>The remainder of this page has been intentionally left blank</em>.]</p> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="text-align:center;margin:0px">2</p></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="MARGIN: 0px 0px 0px 5pt; TEXT-INDENT: 35.95pt; text-align:justify;">This Lock-Up Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof. Delivery of a signed copy of this Lock-Up Agreement by facsimile or e-mail/.pdf transmission shall be effective as the delivery of the original hereof.</p> <p style="MARGIN: 0px 0px 0px 5pt; TEXT-INDENT: 35.95pt; text-align:justify;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:53%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:35%;"> <p style="margin:0px">Very truly yours,</p></td> <td style="width:12%;"> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">(Name - Please Print)</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td>(Signature)</td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">(Name of Signatory, in the case of entities - Please Print)</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">(Title of Signatory, in the case of entities - Please Print)</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">Address:</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="text-align:center;margin:0px">3</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="margin:0px"> <p style="margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>scwo_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html><head><title>scwo_ex991.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 99.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:left;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>374Water Inc. Announces Pricing of $12.2 Million Registered Direct Offering</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">DURHAM, NC / ACCESSWIRE / November 15, 2024 / 374Water Inc. (NASDAQ:SCWO), a global leader in organic waste destruction technology for the municipal, federal, and industrial markets, today announced that it entered into a securities purchase agreement with certain investors to purchase approximately $12.2 million worth of its common stock and warrants in a registered direct offering.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Under the terms of the securities purchase agreement, the Company has agreed to sell 9,783,496 shares of its common stock, par value $0.0001 (&#8220;Common Stock&#8221;) and warrants (&#8220;Warrants&#8221;) to purchase 14,675,244 shares of Common Stock. The Warrants will be exercisable immediately upon issuance, have an exercise price of $1.125 per share, and will expire five years from the initial exercise date. The purchase price for one share of Common Stock and accompanying 1.5 Warrants will be $1.25. </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The gross proceeds to the Company from the registered direct offering are estimated to be approximately $12.2 million, before deducting the placement agent's fees and other estimated offering expenses. The offering is expected to close on or about November 18, 2024, subject to the satisfaction of customary closing conditions.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">D. Boral Capital LLC is acting as exclusive placement agent for the offering.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Orrick, Herrington &amp; Sutcliffe LLP is acting as legal counsel to 374Water Inc. and Sichenzia Ross Ference Carmel LLP is acting as legal counsel to D. Boral Capital LLC for the offering.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The proposed offering of the Common Stock and Warrants described above is being offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-268942) filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) and declared effective by the SEC on December 30, 2022, and the accompanying prospectus contained therein.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The offering is being made only by means of a prospectus supplement and accompanying prospectus. A prospectus supplement describing the terms of the public offering will be filed with the SEC and will form a part of the effective registration statement.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Copies of the prospectus supplement and the accompanying prospectus relating to this offering may be obtained, when available, on the SEC&#8217;s website at http://www.sec.gov or by contacting D. Boral Capital LLC, Attention: Syndicate Department, 590 Madison Avenue, 39th Floor, New York, NY 10022, by email at syndicate@dboralcapital.com, or by telephone at (212) 404-7002.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">1</p></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>About 374Water</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">374Water Inc. (Nasdaq:SCWO) is a global cleantech company providing innovative solutions addressing wastewater treatment and waste management issues within the municipal, federal and industrial markets. 374Water's AirSCWO technology is designed to efficiently destroy and mineralize a broad spectrum of organic non-hazardous and hazardous organic wastes producing safe dischargeable water streams, safe mineral effluent, safe vent gas, and recoverable heat energy. 374Water's AirSCWO technology has the potential to assist its customers to meet discharge requirements, reduce or eliminate disposal costs, remove bottlenecks, and reduce litigation and other risks. 374Water continues to be a leader in innovative waste treatment solutions, dedicated to creating a greener future and eradicating harmful pollutants.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>Forward Looking Statements</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><em>Certain statements in this communication are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements in this press release include statements by the Company relating to the completion of the offering and the satisfaction of customary closing conditions related to the offering. In some cases, forward-looking statements may be identified by the use of words like "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "project," "consider," "predict," "potential," "feel," or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates, beliefs, and projections. While the Company believes these expectations, assumptions, estimates, and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. The forward-looking statements herein are made only as of the date they were first issued, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. </em></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>scwo-20241114.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 11/15/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:scwo="http://scwo.com/20241114" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://scwo.com/20241114">
 <annotation>
  <appinfo>
   <link:roleType roleURI="http://scwo.com/role/Cover" id="Cover">
    <link:definition>000001 - Document - Cover</link:definition>
    <link:usedOn>link:presentationLink</link:usedOn>
    <link:usedOn>link:calculationLink</link:usedOn>
    <link:usedOn>link:definitionLink</link:usedOn>
   </link:roleType>
   <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20241114_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20241114_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20241114_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20241114_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
  </appinfo>
 </annotation>
 <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
 <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
 <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
 <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
 <import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
 <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
 <import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
 <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
 <import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
 <import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
 <import namespace="http://fasb.org/srt-roles/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd" />
 <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
 <import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
 <import namespace="http://fasb.org/us-roles/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd" />
 <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
 <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
 <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>scwo-20241114_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 11/15/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>scwo-20241114_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 11/15/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://scwo.com/role/Cover" xlink:href="scwo-20241114.xsd#Cover" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>scwo-20241114_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 11/15/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://scwo.com/role/Cover" xlink:href="scwo-20241114.xsd#Cover" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>scwo-20241114_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 11/15/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://scwo.com/role/Cover" xlink:href="scwo-20241114.xsd#Cover" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>scwo_ex51img1.jpg
<TEXT>
begin 644 scwo_ex51img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !* (,# 2(  A$! Q$!_\0
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M4EN-FU7SU\1?^3L/ '_7M'_Z,FKZ%K&U&UMI+BVNI+>)[B/[DK("Z]>AZBA
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,4_W:FJ1A1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45963667363344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 14, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">374WATER INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000933972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 14,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0271109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">701 W Main Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Durham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">27701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">609-9677<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SCWO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $J!<ED=B)?*[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $J!
M<EF97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ 2H%R68S^B<U"!   ]Q   !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $J!
M<EF?H!OPL0(  .(,   -              "  84,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ 2H%R69>*NQS     $P(   L              ( !80\
M %]R96QS+RYR96QS4$L! A0#%     @ 2H%R6:K$(A8S 0  (@(   \
M         ( !2A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( $J!<EDD
M'INBK0   /@!   :              "  :H1  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( $J!<EEED'F2&0$  ,\#   3
M      "  8\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
' -D3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="scwo_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>scwo-20241114.xsd</File>
    <File>scwo-20241114_cal.xml</File>
    <File>scwo-20241114_def.xml</File>
    <File>scwo-20241114_lab.xml</File>
    <File>scwo-20241114_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="scwo_8k.htm">scwo_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "scwo_8k.htm": {
   "nsprefix": "scwo",
   "nsuri": "http://scwo.com/20241114",
   "dts": {
    "schema": {
     "local": [
      "scwo-20241114.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "scwo-20241114_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "scwo-20241114_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "scwo-20241114_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "scwo-20241114_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "scwo_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://scwo.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-11-14to2024-11-14",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "strong",
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-11-14to2024-11-14",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "strong",
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001654954-24-014612-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001654954-24-014612-xbrl.zip
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M';#GL"NE"7L70_3I9O1J/VY_ U!+ P04    " !*@7)9Q!/,LY$"  !$"
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MT1DM<8IS@'#Q<WK;F5I>ZY3KDH8"O=9^_?J0D5,8G(^2 "#AY659=A)DW^^
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M#GK%R#L9#^@2 A4YH7J>Z_WJ#LX&OQ2@&5V*G<\0^"Q88X$"L65^!"'B>$5
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MXW:JK165E[HTV($ZZ_14BYQA( 6U<E!?[8.UE(0,+U3I878/;IW$Z@%^C.E
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MXS+TZ1+YF.T_9)K]"N'>APKNYVCTOS IO^DC8"S2?W+/8X'Z$Z8^U<Q/ KK
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MXR J)[>F#EMJ>LWT+>9C]'NI;XSHUS)_C($F/< BIEJ: JZE]8<U<*S5-Y!
M[;C*]H;:K8NR,PAE;D#!FJ:2,0$20TR-,X$%-/<K08"!)6H$E$8DU&&]VM@U
M9I_Q.\1"9]_1=JC/IYL+9C+S^4JN9&$&K9E!CQHU;+)PZ@O*AN"> (3<D2U\
M$UXAYG12;)EHLG:;R[(B7-J,J[P(Q8JB.9]BX-)M.#6 L>&H4?!'IV:)#C&B
M#Z&"DBLNR=!8,O/9.YMHP@N)5=7!IH4*_5*9UFD<5X3+NZ-=/(PH@XJPM3<
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MHBNS>=NMVZX8JK;!EY;FG4_;U;IHMO:-\--FD97%_");2Z>[K%I OZIE!?V
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MP='#/#A^W/VA>%=FQ%:.M.<M>6E@T0WEMU-7]'*0WZL:2U[(L.LQDQ"GN_C
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M!;R,UB_DA"GF*)P5EYGTK,7B)5B(V&,1D]J$FC1W8ZM;!\L%HO=I+EP!*.!
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MAS28+*Q6S;.K0L-.G90UA?,]6.9*H9U*9%"D-@AM"^^EQHGC63%SALO?CW<
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M?RO/6%$P1A,K_#1SB:?]8% 782&;%!-Y/+U36$<*LDD)8G5Z*G$%1][B4+8
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ME3)9X+^#)%%1(T,Z67F1@=!A!A,SNN8^[RG78K9(I)HS;JQ<.%Z'K9:_L,P
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M(D%?7/FA6H8ICWD$P^T4H(M(34S$I&@R U%)UUC@AL&_*A@=YU@8HG'X/<-
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M^D3"7;;K*$LQN\1<D\-"N#/EW$CZ$.98="Y_^L21<?MSQ)*=2]MK_IO<&5Q
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MV>2U&143A2OL4C:6PH]V;$.32U*M9E@2P$%V*+05-[9TU\\>91,U5!_7;O1
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M-@O<4-DFGV,E3?"*WI1MGD:+!"XD+:*\ ;*#FYBTS:*$[5CCOD\S>X2T9GP
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M6P4K6 +$^N$3GG="Q,%4%%\4G?  ?=G3NW9(S2S;JT4$"A'IR77CC,#K08=
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M]6#O_PNLCIG^(LRP*TW9549>WL<'!_L[\]V=P]V=E[L^GP=-O!1HD9AU129
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MQ6(3(_UR?H8_<(Y@-?X5HL*3.0/+PR4CY =,^3+^/;I/^E^<?D1)J21\9M*
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M?EK,98UH9O!:AQ>[(=$^C!#F*H2[O?4:E!@V%G4AO0D_8\"BGB>;PJ%2A$D
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M.4E"<JF'@@2XQ5ZXRX]PLLKB%)UK12]C[W9$*?;L_><[8//-=9^93B0@=L,
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MW*6#W.G:S'U)\!9+@H=WG?'\CSR>_0]02P,$%     @ 2H%R61;(NOSI20
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M*YJ9]Y;ICYAR <*,LE.!VI;9F@YRV_F,:A?P$6*>VLJ$'@\@, ,#C.#J??Z
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MQE6(4PD4Q,4$-)L<%3M#HQYI*HJ4%YM;<A1G:&49.J\H8]HJ4I31#WM^>T:
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M1:/\&M&IR3?'[9-XFT!7ICD?J(JD$#X.(JH[S9E^;'<]GWVQY'O>XN\I@YW
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M7^H=H!6.J2\&F4H8MK!O_)V0"R-UEBO\_6_<O.3^7QX.%1V/U:%?)$;#(#/
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M1X_>,&;%QHXKR%.$026R#G$(4R.3D0E;^ L]+Y9VH!)7"%F(MLR\<%TKE=1
M'7V6(YP68?+ 9:*:6=,XG T8E]9O@;=Z0_K)ZKJR->LZL"JD:15*]U6YEH:N
MO:Q^F1%-@X1:UV'++$[\XP(3E3<GCCO*XS$4VV4?\]9VA;&&1=#FQ#PN&;R<
M_&RW,T.%M)A;92 US>#6@CG6DZBR')JFT5XRHDI;BMZH-E0\)TQ:M)89[6S.
M>H[\F3OF.5/&1.U$W\%,Z<H:>_KO;41O474%:-@J!#5;!B'H[L:$HD?J<!U2
MMF E]$!H%_6NMC9+L=U--<'X?L1)[CJ$;$!]$+VO!_[0A>I&8&D1K9RL6\Q
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M*!:0DY\-JV#G"&-$@AI%.PUZ7JT#WVMRSMJ4$W<UN<<UUE2-<IVAQQ[8K19
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MPI*;IK;L+H.>-U72Z=>[@Q&Y/]R'9S :_#JVS[)W#-#>R/"-_;_ZVW_UM_]
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M@O^D OTT8?Y5Q=YG%?MUZTCZ'UH<_Q=02P,$%     @ 2H%R65T*JL[)"@
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M(<<4T\@_TAQ1;_+LZ.QD*Q%G*C62&%9@'$X 66K6L9,X.55IQ*G=+N-4/^9
MVK&5FZ!$3WA747504 W'=2"4H8LG[1V;D!YMG*.>AFJ05*"J7,F"ZQ&YJ0)?
ME:6I4>I^%E]O0QOTR*':OYK$M%72E=78H(A?\=44 O>= O9;52L3\B=)E5IH
MR*P-_K ;/EFCG=A2J[6V'C7*QUS8*2-C64"Y6/NUMG,T.E"V'4<73\0"Z"KD
M7&I#=69",5.KGP*M]^(0I9H:>XV."TW1+(1RL+.S6"PZ*,T[4SNGD@!^Q$$3
M4?@AQ$W$, 1P#A,-Q&B)O)_"3HA.,FFLY?</NN)"9MJ#@^%<%168V3V -[PV
MUCKTE%#H+]8APUS^ K5S*.-BE8-U8LTW5/^6C>GZ--[>@8:2FDE44JJ<4<6*
M_<_[/4#17G>O_0+$GJR[W)!Y2S05;'5%Q3G*<<1,80-9!?M"%;A!8"=8-4=U
M"O06T0A%-67:YKYQ15WQ\H%F;)U (D0FN,[5%S-J<@6+HUX:59_W6Q2HD:5U
MBE?BY3T6/ S(?&!Q,4/BA\^GL\A/<H]3%TDO;&4RNJPJC%Q,*D.MB67NMW !
MCWZMH+L)N0@]J%8-YP93(!'!D#BCJQ]D[T_PE<!-7DT/[@O>VKZ4-%D:=)GB
MX*&9XN%"9V&&I>Y?6R*%54N993CS?:O;(JJN(3E3-"H<]/;I8BQD*,*E]U@H
MQS.WYB5DQ_CC/G&V7GAU=7UZ=MU^=75S<W4Q$&-4MK>B!V\E2V6'@@>DYY>G
M9S02I2E5Z\^<=O5(D[]3@O4H]EF),KP]=DK>MN4$E 9"FH5<^F?'?X3>??WA
M#UGT22)*,_$<<J/75.2/#2V?C%CWIXW29_+7.&WD%J*9-Z8 T8(&BB)MJE]G
MYSKC&JHH[%QRU0$?K[AW%0@Y@E^N96@RN>!; KU-6"7K.+($U_ V?DCC&^6Y
MW-'%(P/+1^:5G95-T.$/M2,1-B>@FN$9PL?>'842Z.).%'P\,[5+)IPC_^,2
M6 ZRCYV5B&LJ'UR5$P0VP];"%NV9_$VZS%:Q/E__VAK(\@0DJW@8[B6Z/:1R
M%/)NJAC;HE8\J27W2=Q1LT LFHJ+ 'X\)P5-I8^ENE,I6A3'1&;0J5 X-%U^
M2@LT#N0"RG+=(;D9!.0A)<09((\C5)S0YDJ%-;^X\M=*.S84F' T9.$DH(P&
MRY01L!<]%W>:/N[)J8\:VQ ,^$MO5\SS68/T,HUY9SV-04*YW3 FEU"Z(*^H
M!T ;H^\-QXNNM':OE2,F- [B"BC.;&@'=\6"IJ)0FIA4H7**68!">2]M@- Y
M9TYK0(H:Q"=;#378A09T 2<5;ZR])1%'35O@_Q,X]F_1VI0.@JC\^*1^F;#J
M:;AJXGJ>)MB$%[5/P:BXE$5NFUKD]:G6%LP W39F!"V..'@ BHY61#K/J%:O
MOW5Z3@Z_T:._63OSM>+.;,BS3-$[.-A/: @C<2U\L2-&5$,]SMA*G.WZ51>I
MJ3*UN?'>/&*[OU&,U$8U)>SF9&?5*OV1<62D'\-H:TR$W(%XRW$A^$3 ?42T
MNM'2&:'/1*]G*I7G@GB!(@\%I[Z%#; W:8D6M;KTF5)-RP^:+W[6?(M36?I6
M&EG0)^*5\T90]$LC=16\<PRT4G-^V,Q]^9BS[VL*U!V /Q<?$W9$P@UBTH^)
M4O1)@WX&+<Z)$8RIJ]<1;>/T>/--S%CZ.$#QZF-:HEJ?P=@YPK(HG:SA#&A=
MY67]HY'!T_ ;DDUJA*WEX2FR>#>C<=.FI]1:\#4KO^^">W0YOH"FZ$QCC^P_
MX=;\-H0&++56(Q%.YG-K@.&WA5W$5% 5\3LG@_I)_1*1@BVAFH$;L-@/-03(
MD>GM(NR2:I=6.6[GU]'\ZE)R_[6TM>O7NG@61UO.FFBNCP@0FSJFLYX6R14H
MT LA^K(4"\4OD9RO*YHLJ64P%-#L,@MZA51G5 X"699HY&+#L]UZ;;_0HWQL
MI,X]MV/LV$TK9\>F@2"$:%5F=9?FU)QNX]<NCTK',P]V9H(JG/&58?PB5-8%
M(1J33II\J>;Q6!,$)!&]L0)$_[\3_"_L!/O;G=N?T8OQ?P0Z_A=02P$"% ,4
M    " !*@7)98$=>8(4$  "#%@  $0              @ $     <V-W;RTR
M,#(T,3$Q-"YX<V102P$"% ,4    " !*@7)9R?U]>-H!  "+ P  %0
M        @ &T!   <V-W;RTR,#(T,3$Q-%]C86PN>&UL4$L! A0#%     @
M2H%R6<03S+.1 @  1 @  !4              ( !P08  '-C=V\M,C R-#$Q
M,31?9&5F+GAM;%!+ 0(4 Q0    ( $J!<EELZ<>A&P8  *,Y   5
M      "  84)  !S8W=O+3(P,C0Q,3$T7VQA8BYX;6Q02P$"% ,4    " !*
M@7)9/C2'/Y($  !T)   %0              @ '3#P  <V-W;RTR,#(T,3$Q
M-%]P<F4N>&UL4$L! A0#%     @ 2H%R63"2,J!V&   .Y,   L
M     ( !F!0  '-C=V]?.&LN:'1M4$L! A0#%     @ 2H%R6;(S9I#TA@
MV] "  X              ( !-RT  '-C=V]?97@Q,#$N:'1M4$L! A0#%
M  @ 2H%R61O24:O -   $@H!  X              ( !5[0  '-C=V]?97@Q
M,#(N:'1M4$L! A0#%     @ 2H%R60_9)V6]#P  1%(   X
M ( !0^D  '-C=V]?97@Q,#,N:'1M4$L! A0#%     @ 2H%R61;(NOSI20
M(J\!  T              ( !+/D  '-C=V]?97@T,2YH=&U02P$"% ,4
M" !*@7)9C?,!>740   O0P  #0              @ % 0P$ <V-W;U]E>#4Q
M+FAT;5!+ 0(4 Q0    ( $J!<EE="JK.R0H  &@D   .              "
I >!3 0!S8W=O7V5X.3DQ+FAT;5!+!08     #  , .H"  #57@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>scwo_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="scwo-20241114.xsd" xlink:type="simple"/>
    <context id="From2024-11-14to2024-11-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2024-11-14</startDate>
            <endDate>2024-11-14</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2024-11-14to2024-11-14" id="ixv-420">0000933972</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2024-11-14to2024-11-14" id="ixv-421">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2024-11-14to2024-11-14" id="ixv-441">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2024-11-14to2024-11-14" id="ixv-442">2024-11-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2024-11-14to2024-11-14" id="ixv-443">374WATER INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-11-14to2024-11-14" id="ixv-444">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2024-11-14to2024-11-14" id="ixv-445">001-41420</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-11-14to2024-11-14" id="ixv-446">88-0271109</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-11-14to2024-11-14" id="ixv-447">701 W Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-11-14to2024-11-14" id="ixv-448">Suite 410</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-11-14to2024-11-14" id="ixv-449">Durham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-11-14to2024-11-14" id="ixv-450">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-11-14to2024-11-14" id="ixv-451">27701</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-11-14to2024-11-14" id="ixv-452">440</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-11-14to2024-11-14" id="ixv-453">609-9677</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2024-11-14to2024-11-14" id="ixv-454">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2024-11-14to2024-11-14" id="ixv-455">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2024-11-14to2024-11-14" id="ixv-456">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2024-11-14to2024-11-14" id="ixv-457">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2024-11-14to2024-11-14" id="ixv-458">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-11-14to2024-11-14" id="ixv-459">SCWO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-11-14to2024-11-14" id="ixv-460">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-11-14to2024-11-14" id="ixv-461">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
